RO8 personal page - To The Moon

RO8

RO8

No personal profile

400Follow

32Followers

1Topic

0Badge

2023-06-01

Great ariticle, would you like to share it?

@Tiger_Newspress:Best Gold ETFs: Top Funds for Investing in Gold

2022-10-23

Lol

2022-08-06

ETF

3 First-Rate ETFs for Stock Dividends

2022-06-28

Novavax

3 Reasons to Buy Novavax and 1 to Sell

2022-05-08

Sharing

2022-05-08

NVAX

Novavax: Don't Catch The Falling Knives

2022-05-08

Tesla

Tesla: Overvalued By 85.26% And Not A Technology Company

2022-05-08

$JPMorgan Inflation Managed Bond ETF(JCPI)$sharing

2022-05-08

Sharing

@Capital_Insights:Why Market Plummeted? Joining the Vote of 8 Biggest Factors!

2022-05-08

$Novavax(NVAX)$[Cry]

2022-05-06

Ok

Draftkings Shares Jumped 5% in Premarket Trading as Q1 Sales Beat Estimate

2022-05-06

Ok

Is It Safer to Pull Your Money Out of the Stock Market or Keep Investing for Now?

2022-05-06

Ok

Down 42%, This Dow Stock Is a Screaming Buy in May

2022-05-06

Sharing

Sorry, the original content has been removed

2022-05-06

$Novavax(NVAX)$sharing

2022-05-06

$Invesco QQQ Trust(QQQ)$sharing

2022-05-05

$Novavax(NVAX)$[Cry]

2022-05-05

$VanEck Gold Miners ETF(GDX)$sharing

2022-05-05

$Thermo Fisher Scientific(TMO)$sharing

2022-05-05

$Novavax(NVAX)$[Cry]

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":3585981947031986,"uuid":"3585981947031986","gmtCreate":1622890172374,"gmtModify":1622905348147,"name":"RO8","pinyin":"ro8","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":32,"headSize":400,"tweetSize":480,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.76%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":182472669585536,"gmtCreate":1685558232119,"gmtModify":1685558235731,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Great ariticle, would you like to share it?","listText":"Great ariticle, would you like to share it?","text":"Great ariticle, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/182472669585536","repostId":"9942615702","repostType":1,"repost":{"id":9942615702,"gmtCreate":1681210190306,"gmtModify":1681210403063,"author":{"id":"3527667628464496","authorId":"3527667628464496","name":"Tiger_Newspress","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"Best Gold ETFs: Top Funds for Investing in Gold","htmlText":"Gold gained 9% in Q1 2023, but see-sawed on bond market volatility. A surge in March to record the highest monthly inflows since 2019, reversed two weak months for global gold ETFs and futures investment. The recent surge in gold is impressive. Investing in gold has never been easier, with some gold ETFs providing a simple, cost-efficient way to add some gold exposure to your investment portfolio.Which gold ETF is best?1. <a href=\"https://ttm.financial/S/GLD\">$SPDR Gold Shares ETF(GLD)$</a> (GLD, 02840HK, O87SI)<a href=\"https://ttm.financial/S/02840\">$SPDR Gold Shares ETF(02840)$</a> is one of the most popular ETFs available. The fund invests in physical gold, and its performance is highly correlated to gold spot prices.<a href=\"https://ttm.financial/S/O87.SI\">$SPDR Gold Shares ETF(O87.SI)</a>","listText":"Gold gained 9% in Q1 2023, but see-sawed on bond market volatility. A surge in March to record the highest monthly inflows since 2019, reversed two weak months for global gold ETFs and futures investment. The recent surge in gold is impressive. Investing in gold has never been easier, with some gold ETFs providing a simple, cost-efficient way to add some gold exposure to your investment portfolio.Which gold ETF is best?1. <a href=\"https://ttm.financial/S/GLD\">$SPDR Gold Shares ETF(GLD)$</a> (GLD, 02840HK, O87SI)<a href=\"https://ttm.financial/S/02840\">$SPDR Gold Shares ETF(02840)$</a> is one of the most popular ETFs available. The fund invests in physical gold, and its performance is highly correlated to gold spot prices.<a href=\"https://ttm.financial/S/O87.SI\">$SPDR Gold Shares ETF(O87.SI)</a>","text":"Gold gained 9% in Q1 2023, but see-sawed on bond market volatility. A surge in March to record the highest monthly inflows since 2019, reversed two weak months for global gold ETFs and futures investment. The recent surge in gold is impressive. Investing in gold has never been easier, with some gold ETFs providing a simple, cost-efficient way to add some gold exposure to your investment portfolio.Which gold ETF is best?1. $SPDR Gold Shares ETF(GLD)$ (GLD, 02840HK, O87SI)$SPDR Gold Shares ETF(02840)$ is one of the most popular ETFs available. The fund invests in physical gold, and its performance is highly correlated to gold spot prices.$SPDR Gold Shares ETF(O87.SI)","images":[{"img":"https://community-static.tradeup.com/news/b9cceb9203f16d0475de4326cfc541fe","width":"749","height":"1028"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9942615702","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9981267227,"gmtCreate":1666523265170,"gmtModify":1676537765356,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Lol","listText":"Lol","text":"Lol","images":[{"img":"https://community-static.tradeup.com/news/90d63b3aefa1be6ab1ff26ec8b5afbdb","width":"1080","height":"1665"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9981267227","isVote":1,"tweetType":1,"viewCount":178,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9905939770,"gmtCreate":1659792101491,"gmtModify":1703766569559,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"ETF&nbsp;","listText":"ETF&nbsp;","text":"ETF","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9905939770","repostId":"2257198726","repostType":4,"repost":{"id":"2257198726","pubTimestamp":1659757800,"share":"https://www.laohu8.com/m/news/2257198726?lang=&edition=full","pubTime":"2022-08-06 11:50","market":"us","language":"en","title":"3 First-Rate ETFs for Stock Dividends","url":"https://stock-news.laohu8.com/highlight/detail?id=2257198726","media":"Motley Fool","summary":"You can't go wrong with reliable income.","content":"<html><head></head><body><p>It can&#39;t be overstated just how pivotal dividends can be to an investors&#39; total returns -- especially when reinvested. From 1960 through 2021, reinvested dividends accounted for 84% of the total return of the <b>S&amp;P 500</b>, according to Hartford Funds.</p><p>In other words, dividends can be powerful. If you&#39;re looking to invest in dividend-paying stocks, look no further than dividend-focused exchange-traded funds (ETFs).</p><p>ETFs that prioritize dividends can provide the benefit of having higher dividend yields as well as diversification, one of the key pillars of investing. Here are three first-rate dividend ETFs to check out.</p><h2>1. <a href=\"https://laohu8.com/S/VYM\">Vanguard High Dividend Yield ETF</a></h2><p>The <b>Vanguard High Dividend Yield ETF</b> is a popular option with a fairly broad approach to which stocks it holds. Excluding REITs, the fund consists of 443 public U.S. companies that have paid out above-average dividends in the previous 12 months. With the Vanguard High Dividend Yield ETF, investors will get exposure to large-cap companies spanning all 11 sectors. And since it&#39;s market-cap weighted, larger companies make up the bulk of the fund.</p><p>A great thing about this ETF is its low cost with an expense ratio of just 0.06%. A small difference in percentages may not seem like much on paper, but higher expense ratios can eat away at your returns over time. With trailing-12-month payouts of $3.20 per share (or a 3.0% yield as of this writing), it&#39;s also in line with some top-paying dividend ETFs.</p><h2>2. SPDR S&amp;P Dividend ETF</h2><p>The <b>SPDR S&amp;P Dividend ETF</b> is a bit more selective in the stocks it includes, only screening for companies that have consistently increased their dividends at least 20 consecutive years. Although that&#39;s five years less than what it takes to attain the Dividend Aristocrat title, this ETF still consists of many of them, providing a bit more sense of reliability.</p><p>The index is weighted by dividend yield, so the higher a company&#39;s yield, the greater its representation in the fund. There are only 119 companies total, but the largest holding, <b>Franklin Resources</b>, only makes up 1.85% of it. The companies within the fund are chosen each January and reweighted every quarter.</p><p>The fund paid out $3.35 over the past year (around a 2.7% yield). However, one downside to the SPDR S&amp;P Dividend ETF is its expense ratio, which comes in a bit pricier than other options at 0.35%.</p><h2>3. <a href=\"https://laohu8.com/S/EMDI\">iShares</a> Core High Dividend ETF</h2><p>The <b><a href=\"https://laohu8.com/S/EMEY\">iShares</a> Core High Dividend ETF</b> is the most selective of the three listed here, holding only 75 U.S. stocks that the fund has screened for financial health. This ETF consists mostly of large-cap stocks, and it&#39;s a bit more top-heavy than the other ETFs with the top three holdings -- <b>ExxonMobil</b>, <b>Johnson &amp; Johnson</b>, and <b>Chevron</b> -- making up over 19% of the fund. The top three sectors -- healthcare, energy, and consumer staples -- make up about 58% of the fund as well.</p><p>With a $3.16 trailing-12-month payout (or a 3.1% yield), it can be a lucrative choice for investors looking to kill two birds with one stone with dividends and large-cap investing. It&#39;s also low cost with a 0.08% expense ratio.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 First-Rate ETFs for Stock Dividends</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 First-Rate ETFs for Stock Dividends\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-06 11:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/08/05/3-first-rate-etfs-for-stock-dividends/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It can't be overstated just how pivotal dividends can be to an investors' total returns -- especially when reinvested. From 1960 through 2021, reinvested dividends accounted for 84% of the total ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/08/05/3-first-rate-etfs-for-stock-dividends/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HDV":"iShares High Dividend Equity Fun","VYM":"红利股ETF-Vanguard","SDY":"股息指数ETF-SPDR S&P"},"source_url":"https://www.fool.com/investing/2022/08/05/3-first-rate-etfs-for-stock-dividends/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2257198726","content_text":"It can't be overstated just how pivotal dividends can be to an investors' total returns -- especially when reinvested. From 1960 through 2021, reinvested dividends accounted for 84% of the total return of the S&P 500, according to Hartford Funds.In other words, dividends can be powerful. If you're looking to invest in dividend-paying stocks, look no further than dividend-focused exchange-traded funds (ETFs).ETFs that prioritize dividends can provide the benefit of having higher dividend yields as well as diversification, one of the key pillars of investing. Here are three first-rate dividend ETFs to check out.1. Vanguard High Dividend Yield ETFThe Vanguard High Dividend Yield ETF is a popular option with a fairly broad approach to which stocks it holds. Excluding REITs, the fund consists of 443 public U.S. companies that have paid out above-average dividends in the previous 12 months. With the Vanguard High Dividend Yield ETF, investors will get exposure to large-cap companies spanning all 11 sectors. And since it's market-cap weighted, larger companies make up the bulk of the fund.A great thing about this ETF is its low cost with an expense ratio of just 0.06%. A small difference in percentages may not seem like much on paper, but higher expense ratios can eat away at your returns over time. With trailing-12-month payouts of $3.20 per share (or a 3.0% yield as of this writing), it's also in line with some top-paying dividend ETFs.2. SPDR S&P Dividend ETFThe SPDR S&P Dividend ETF is a bit more selective in the stocks it includes, only screening for companies that have consistently increased their dividends at least 20 consecutive years. Although that's five years less than what it takes to attain the Dividend Aristocrat title, this ETF still consists of many of them, providing a bit more sense of reliability.The index is weighted by dividend yield, so the higher a company's yield, the greater its representation in the fund. There are only 119 companies total, but the largest holding, Franklin Resources, only makes up 1.85% of it. The companies within the fund are chosen each January and reweighted every quarter.The fund paid out $3.35 over the past year (around a 2.7% yield). However, one downside to the SPDR S&P Dividend ETF is its expense ratio, which comes in a bit pricier than other options at 0.35%.3. iShares Core High Dividend ETFThe iShares Core High Dividend ETF is the most selective of the three listed here, holding only 75 U.S. stocks that the fund has screened for financial health. This ETF consists mostly of large-cap stocks, and it's a bit more top-heavy than the other ETFs with the top three holdings -- ExxonMobil, Johnson & Johnson, and Chevron -- making up over 19% of the fund. The top three sectors -- healthcare, energy, and consumer staples -- make up about 58% of the fund as well.With a $3.16 trailing-12-month payout (or a 3.1% yield), it can be a lucrative choice for investors looking to kill two birds with one stone with dividends and large-cap investing. It's also low cost with a 0.08% expense ratio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":349,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9042057251,"gmtCreate":1656411324473,"gmtModify":1676535823090,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Novavax&nbsp;","listText":"Novavax&nbsp;","text":"Novavax","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9042057251","repostId":"2246803790","repostType":4,"repost":{"id":"2246803790","pubTimestamp":1656382573,"share":"https://www.laohu8.com/m/news/2246803790?lang=&edition=full","pubTime":"2022-06-28 10:16","market":"us","language":"en","title":"3 Reasons to Buy Novavax and 1 to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2246803790","media":"Motley Fool","summary":"What does the future hold for this COVID-19 vaccination stock?","content":"<html><head></head><body><p><b>Novavax</b> is a pandemic stock. That&#39;s why it soared in 2020-21 when the world faced the worst pandemic since the influenza outbreak of 1918. When COVID-19 hit, this vaccine biotech made an almost impossible run, from a low of $4 a share all the way to $330.</p><p>Now it&#39;s down to $50, and the company&#39;s market cap is under $4 billion. Is it a buy at these prices? Here are three arguments for buying Novavax stock and one reason for why you might want to avoid these shares.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a59fcd638ddc65fc898da7b619b04516\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"/><span>Image source: Getty Images.</span></p><h2>Green Flag #1: Huge revenue in 2022 plus profits!</h2><p>In the first quarter, Novavax reported its first profitable quarter as a public company, with $200 million in profits off of $700 million in sales. That&#39;s a huge step up for a biotech, which has been unprofitable since it hit the public markets way back in the 20th century (1995 to be exact).</p><p>Novavax is a scrappy underdog that has survived for almost three decades without making any money. When Stan Erck arrived at the CEO slot in 2011, the company turned its focus toward vaccines to thwart pandemics. So if you&#39;re worried about severe acute respiratory syndrome (SARS), Novavax has discovered a potential vaccine for that. The biotech also has vaccine candidates in its pipeline for Ebola, malaria, Middle East respiratory syndrome (MERS), and influenza.</p><p>None of those drugs have been approved yet (Novavax is still waiting for its first FDA approval), but all of this scientific research gave the small biotech a big advantage when it came to combating the new coronavirus that hit the world two years ago. Based on its research, Novavax was awarded a massive $399 million check from the Bill Gates-funded Coalition for Epidemic Preparedness Innovations (CEPI). It&#39;s still the largest grant CEPI has ever made.</p><p>Novavax got an even bigger check from the U.S. government when Operation Warp Speed (OWS) pre-ordered 100 million doses of the company&#39;s COVID-19 vaccine and paid $1.6 billion in advance. Multiple governments around the world followed suit. So far, Novavax has received orders for 2 billion doses of its COVID-19 vaccine. Management estimates it will make over $4 billion in revenue in 2022 and maybe as much as $5 billion.</p><h2>Green Flag #2: The stock is cheap, and the opportunity massive</h2><p>At the end of Q1, Novavax reported $1.6 billion in cash. So right now, the stock is trading at less than three times cash. Its forward price-to-earnings (P/E) ratio is 1.6, and its price-to-sales (P/S) ratio is 1.8. This is incredibly cheap given how fast revenue is escalating. In Q1, the biotech delivered 42 million doses of the COVID vaccine to the European Union (EU), Canada, South Korea, Australia, New Zealand, and Indonesia.</p><p>While 42 million is a lot, Novavax&#39;s massive roll-out has just begun. The company anticipates an Emergency Use Authorization (EUA) from American regulators this month. A few weeks ago, the FDA&#39;s advisory committee voted 21-0 that Novavax&#39;s vaccine should be available to the people of the United States. If and when the FDA follows the advice of its advisory committee, Novavax will be allowed to start shipping 110 million doses of vaccine in the U.S.</p><p>While the stock market is waiting for the FDA&#39;s decision, most of Novavax&#39;s market opportunity is actually abroad. The company has already received authorizations to ship its vaccines to over 170 countries. This is huge for Novavax as the biotech has advance-purchase agreements for up to 430 million doses, or 10 times what it delivered in Q1.</p><h2>Green Flag #3: At least $7 billion in near-term revenue</h2><p>If 42 million doses brought in $700 million in Q1, what will 430 million doses bring in? And note that these contracts are in many of the same places that were responsible for the Q1 revenue (EU, Canada, Australia, and New Zealand).</p><p>While Novavax keeps its pricing data secret, these deals were made when the pandemic was at its worst. If the price points are similar, the company might pull in $7 billion from these contracts alone (some of this revenue will likely spill over into 2023). So management&#39;s estimate of $4 billion to $5 billion in revenues for 2022 seems very doable.</p><p>What&#39;s remarkable is that this $7 billion does not include <i>any</i> revenue from the 110 million doses in the U.S.; nor does it include the 1.1 billion doses that Novavax is distributing to COVID-19 Vaccines Global Access (COVAX) as part of its CEPI obligations, nor another 400 million doses the company is distributing as part of licensing agreements in Asia. So to my mind, this back-of-the-envelope $7 billion calculation is a floor -- not a ceiling.</p><h2>Red Flag: Can Novavax deliver 2 billion doses?</h2><p>The big question for Novavax is not in regard to its science -- some observers call its vaccine best-in-class -- but rather the manufacturing issues which have dogged the tiny biotech. Novavax has signed multiple contracts with third-party sites to manufacture its COVID vaccine. So far, however, the only site that has been approved by regulators is the Serum Institute of India (the largest vaccine manufacturer in the world by volume). Some of the other manufacturing sites have been hampered by purity issues.</p><p>It&#39;s these manufacturing difficulties that have caused a year-long delay in getting this vaccine to market in the U.S. Novavax&#39;s share price hit $330 in the days after the company released its amazing phase 3 data for its COVID vaccine in early 2021.  But after all the delays, the stock has seen a massive price drop to $50 a share, while <b>Pfizer </b>and <b>Moderna</b> have vaccinated most of the country.</p><p>Nonetheless, I&#39;m very bullish that Novavax will solve its manufacturing issues. The Serum Institute can and will produce a billion doses of the vaccine. (That&#39;s the manufacturer Novavax has relied on to get its EUAs around the world). And now additional manufacturing sites are approaching readiness. In April, the biotech submitted data from another highly regarded manufacturer, SK Bioscience, to European health authorities. And in Q2, Novavax will file data from its own manufacturing site in the Czech Republic. That state-of-the-art facility will ultimately manufacture another one billion doses a year for Novavax.</p><h2>What is the future for Novavax?</h2><p>The market, with its short-term dynamics, seems to think that COVID-19 is over. While I wish this were the case, I&#39;m afraid it&#39;s highly unlikely. Since COVID mutates like flu viruses, many of us may well need to be vaccinated annually. COVID hospitalizations spiked dramatically in the winters of 2020 and 2021, so that is likely to happen this year too. Like the flu, the worst cases of COVID seem to be seasonal.</p><p>In that regard, Novavax is in the lead in finding a flu/COVID combo vaccine. The company has already started clinical trials and will advance its candidate into a phase 2 trial later this year. Over the next year or two, I expect Novavax revenue to spike a lot higher. But the real gains will happen if and when Novavax is first to market with its COVID/flu combo shot.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Reasons to Buy Novavax and 1 to Sell</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Reasons to Buy Novavax and 1 to Sell\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-06-28 10:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/06/27/3-reasons-to-buy-novavax-and-1-to-sell/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Novavax is a pandemic stock. That's why it soared in 2020-21 when the world faced the worst pandemic since the influenza outbreak of 1918. When COVID-19 hit, this vaccine biotech made an almost ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/06/27/3-reasons-to-buy-novavax-and-1-to-sell/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2022/06/27/3-reasons-to-buy-novavax-and-1-to-sell/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2246803790","content_text":"Novavax is a pandemic stock. That's why it soared in 2020-21 when the world faced the worst pandemic since the influenza outbreak of 1918. When COVID-19 hit, this vaccine biotech made an almost impossible run, from a low of $4 a share all the way to $330.Now it's down to $50, and the company's market cap is under $4 billion. Is it a buy at these prices? Here are three arguments for buying Novavax stock and one reason for why you might want to avoid these shares.Image source: Getty Images.Green Flag #1: Huge revenue in 2022 plus profits!In the first quarter, Novavax reported its first profitable quarter as a public company, with $200 million in profits off of $700 million in sales. That's a huge step up for a biotech, which has been unprofitable since it hit the public markets way back in the 20th century (1995 to be exact).Novavax is a scrappy underdog that has survived for almost three decades without making any money. When Stan Erck arrived at the CEO slot in 2011, the company turned its focus toward vaccines to thwart pandemics. So if you're worried about severe acute respiratory syndrome (SARS), Novavax has discovered a potential vaccine for that. The biotech also has vaccine candidates in its pipeline for Ebola, malaria, Middle East respiratory syndrome (MERS), and influenza.None of those drugs have been approved yet (Novavax is still waiting for its first FDA approval), but all of this scientific research gave the small biotech a big advantage when it came to combating the new coronavirus that hit the world two years ago. Based on its research, Novavax was awarded a massive $399 million check from the Bill Gates-funded Coalition for Epidemic Preparedness Innovations (CEPI). It's still the largest grant CEPI has ever made.Novavax got an even bigger check from the U.S. government when Operation Warp Speed (OWS) pre-ordered 100 million doses of the company's COVID-19 vaccine and paid $1.6 billion in advance. Multiple governments around the world followed suit. So far, Novavax has received orders for 2 billion doses of its COVID-19 vaccine. Management estimates it will make over $4 billion in revenue in 2022 and maybe as much as $5 billion.Green Flag #2: The stock is cheap, and the opportunity massiveAt the end of Q1, Novavax reported $1.6 billion in cash. So right now, the stock is trading at less than three times cash. Its forward price-to-earnings (P/E) ratio is 1.6, and its price-to-sales (P/S) ratio is 1.8. This is incredibly cheap given how fast revenue is escalating. In Q1, the biotech delivered 42 million doses of the COVID vaccine to the European Union (EU), Canada, South Korea, Australia, New Zealand, and Indonesia.While 42 million is a lot, Novavax's massive roll-out has just begun. The company anticipates an Emergency Use Authorization (EUA) from American regulators this month. A few weeks ago, the FDA's advisory committee voted 21-0 that Novavax's vaccine should be available to the people of the United States. If and when the FDA follows the advice of its advisory committee, Novavax will be allowed to start shipping 110 million doses of vaccine in the U.S.While the stock market is waiting for the FDA's decision, most of Novavax's market opportunity is actually abroad. The company has already received authorizations to ship its vaccines to over 170 countries. This is huge for Novavax as the biotech has advance-purchase agreements for up to 430 million doses, or 10 times what it delivered in Q1.Green Flag #3: At least $7 billion in near-term revenueIf 42 million doses brought in $700 million in Q1, what will 430 million doses bring in? And note that these contracts are in many of the same places that were responsible for the Q1 revenue (EU, Canada, Australia, and New Zealand).While Novavax keeps its pricing data secret, these deals were made when the pandemic was at its worst. If the price points are similar, the company might pull in $7 billion from these contracts alone (some of this revenue will likely spill over into 2023). So management's estimate of $4 billion to $5 billion in revenues for 2022 seems very doable.What's remarkable is that this $7 billion does not include any revenue from the 110 million doses in the U.S.; nor does it include the 1.1 billion doses that Novavax is distributing to COVID-19 Vaccines Global Access (COVAX) as part of its CEPI obligations, nor another 400 million doses the company is distributing as part of licensing agreements in Asia. So to my mind, this back-of-the-envelope $7 billion calculation is a floor -- not a ceiling.Red Flag: Can Novavax deliver 2 billion doses?The big question for Novavax is not in regard to its science -- some observers call its vaccine best-in-class -- but rather the manufacturing issues which have dogged the tiny biotech. Novavax has signed multiple contracts with third-party sites to manufacture its COVID vaccine. So far, however, the only site that has been approved by regulators is the Serum Institute of India (the largest vaccine manufacturer in the world by volume). Some of the other manufacturing sites have been hampered by purity issues.It's these manufacturing difficulties that have caused a year-long delay in getting this vaccine to market in the U.S. Novavax's share price hit $330 in the days after the company released its amazing phase 3 data for its COVID vaccine in early 2021.  But after all the delays, the stock has seen a massive price drop to $50 a share, while Pfizer and Moderna have vaccinated most of the country.Nonetheless, I'm very bullish that Novavax will solve its manufacturing issues. The Serum Institute can and will produce a billion doses of the vaccine. (That's the manufacturer Novavax has relied on to get its EUAs around the world). And now additional manufacturing sites are approaching readiness. In April, the biotech submitted data from another highly regarded manufacturer, SK Bioscience, to European health authorities. And in Q2, Novavax will file data from its own manufacturing site in the Czech Republic. That state-of-the-art facility will ultimately manufacture another one billion doses a year for Novavax.What is the future for Novavax?The market, with its short-term dynamics, seems to think that COVID-19 is over. While I wish this were the case, I'm afraid it's highly unlikely. Since COVID mutates like flu viruses, many of us may well need to be vaccinated annually. COVID hospitalizations spiked dramatically in the winters of 2020 and 2021, so that is likely to happen this year too. Like the flu, the worst cases of COVID seem to be seasonal.In that regard, Novavax is in the lead in finding a flu/COVID combo vaccine. The company has already started clinical trials and will advance its candidate into a phase 2 trial later this year. Over the next year or two, I expect Novavax revenue to spike a lot higher. But the real gains will happen if and when Novavax is first to market with its COVID/flu combo shot.","news_type":1},"isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9062329878,"gmtCreate":1652008928594,"gmtModify":1676535013001,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Sharing&nbsp;","listText":"Sharing&nbsp;","text":"Sharing","images":[{"img":"https://community-static.tradeup.com/news/36665c190f76fcb63596db159e05532a","width":"1080","height":"2431"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9062329878","isVote":1,"tweetType":1,"viewCount":137,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9062320732,"gmtCreate":1652008810326,"gmtModify":1676535012993,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"NVAX&nbsp;","listText":"NVAX&nbsp;","text":"NVAX","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9062320732","repostId":"1117562991","repostType":4,"repost":{"id":"1117562991","pubTimestamp":1651978981,"share":"https://www.laohu8.com/m/news/1117562991?lang=&edition=full","pubTime":"2022-05-08 11:03","market":"us","language":"en","title":"Novavax: Don't Catch The Falling Knives","url":"https://stock-news.laohu8.com/highlight/detail?id=1117562991","media":"Seeking Alpha","summary":"SummaryNovavax is scheduled to report its Q1 earnings on May 9. Unfortunately, the situation in the ","content":"<html><head></head><body><p>Summary</p><ul><li>Novavax is scheduled to report its Q1 earnings on May 9. Unfortunately, the situation in the COVID-19 vaccines market has changed significantly. Now, we have an oversupply reality.</li><li>Yet, Novavax still does not have its EUA from the US FDA. Also, we think its revenue visibility for FY22-23 is at risk.</li><li>Therefore, we revise our rating on NVAX stock from Buy to Sell. Don&#39;t catch the falling knives from here.</li></ul><p>Investment Thesis</p><p>Novavax, Inc. (NASDAQ:NVAX) is slated to report its Q1 earnings on May 9, ahead of the FDA review of its EUAfor its COVID-19 vaccine. As a result, Novavax investors have been waiting for a considerable amount of time. Unfortunately, much has changed over the last few months since its FQ4 earnings call.</p><p>In April, Moderna (MRNA) highlighted that the world now has an oversupply of COVID-19 vaccines. It also added that COVAX declined to take up additional options for more vaccines. In its Q1 earnings call, it also highlighted that its FY22 COVID-19 vaccines guidance could be impacted &#34;if COVAX is unable to confirm demand aligned to their contracted volume in the 2022 calendar year.&#34;</p><p>Furthermore, Novavax&#39;s key manufacturing partner Serum Institute of India, reportedly suspended the production of COVID-19 vaccines back in December 2021. It highlighted that &#34;supply outpaced demand amid global vaccine glut.&#34;</p><p>As a result, NVAX stock investors should not be surprised that its stock has collapsed 83% from its 2021 highs. We were cautiously optimistic in a previous update, as it had managed to gain several EUAs outside of the US. However, we think the tide has turned significantly for Novavax.</p><p>Despite the significant battering in its price, we think the time has come for Novavax investors to use any rally in NVAX stock to cut exposure partially or fully.</p><p>As a result, we revise our rating on NVAX stock from Buy to Sell.</p><p>NVAX Stock Deserves Its Lower Valuation Multiples<img src=\"https://static.tigerbbs.com/03a4e51160f8b018f1c769d47982b446\" tg-width=\"640\" tg-height=\"384\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>NVAX stock NTM revenue multiples(TIKR)</p><p>NVAX stock last traded at an NTM revenue multiple of 0.8x. It was well below the valuations of its two leading mRNA counterparts, Moderna and BioNTech (BNTX) stock. We think the bifurcation is justified, given the proven commercial success of its mRNA peers&#39; vaccines. Furthermore, they have several pipelines developed on top of their proven mRNA platforms that should attract more confidence from biotech investors.</p><p>While Novavax keeps its investors on tenterhooks, Moderna and BioNTech have capitalized on its tardiness and dominated the COVID-19 vaccines market. So even though we recognized that Novavax&#39;s vaccine holds tremendous promise, it&#39;s simply too little too late.</p><p>Furthermore, the reality in The African Union and COVAX accentuated the waning demand for COVID-19 vaccines as they dealt with several challenges. Bloomberg reported that these &#34;lower-income countries left behind in the global rollout are now grappling with a lack of funds, hesitancy, supply-chain obstacles, and other factors that are hampering distribution.&#34; As a result, &#34;the vaccine landscape has changed drastically in recent months.&#34;</p><p>Notably, Pfizer (PFE) also declined to provide an update on FY23&#39;s visibility, despite reiterating its guidance for 2022. Therefore, we believe that the oversupply situation in 2022 would likely drag on further to 2023. As a result, Novavax&#39;s estimates for FY22-23 could have significant downside risks.</p><p>Novavax&#39;s Estimates Revised Downwards<img src=\"https://static.tigerbbs.com/fc50807c7a93b44fec42a8bb17d30faf\" tg-width=\"640\" tg-height=\"395\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Novavax revenue consensus estimates(S&amp;P Capital IQ)</p><p>Hence, investors shouldn&#39;t be surprised that Novavax&#39;s revenue estimates have been revised downwards to reflect these uncertainties. The updated consensus estimates suggest the revenue bar that Novavax needs to clear in Q1 is $845.2M, down from March&#39;s estimates of $909.08M. However, the Street remains convinced that Novavax&#39;s revenue growth could gain momentum from Q2. Therefore, we believe that it&#39;s imperative for Novavax to reiterate or raise its previous FY22 guidance of $4.5B to assuage the market.</p><p>Nevertheless, we believe that the market remains uncertain over its guidance from FY23. As a result, we think the lack of visibility from its mRNA counterparts could continue to hamper NVAX stock momentum moving forward. Moreover, we believe it will be a tall order for management to communicate guidance beyond FY22, given the dynamics in the supply situation surrounding the COVID-19 vaccines.</p><p>Is NVAX Stock A Buy, Sell, Or Hold?<img src=\"https://static.tigerbbs.com/1fe89d7d4e0995b3b31ef612aa3733da\" tg-width=\"640\" tg-height=\"356\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>NVAX stock price chart(TradingView)</p><p>The bull trap in early 2021 proved prescient for investors who sold into that rally and took profit astutely. NVAX stock bagholders are now left with a mess as it broke below a critical support zone ($76) in April 2022. A recovery above that zone will be critical for NVAX stock to regain its support. Otherwise, it is increasingly likely that the stock is currently in free fall to an undetermined support level.</p><p>Therefore, we think the speculative run on NVAX stock has come to an abrupt end. Accordingly, we <i>revise our rating on NVAX stock from Buy to Sell</i>ahead of its Q1 card.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax: Don't Catch The Falling Knives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax: Don't Catch The Falling Knives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-08 11:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4508330-novavax-falling-knive-stock-sell><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryNovavax is scheduled to report its Q1 earnings on May 9. Unfortunately, the situation in the COVID-19 vaccines market has changed significantly. Now, we have an oversupply reality.Yet, Novavax ...</p>\n\n<a href=\"https://seekingalpha.com/article/4508330-novavax-falling-knive-stock-sell\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/article/4508330-novavax-falling-knive-stock-sell","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117562991","content_text":"SummaryNovavax is scheduled to report its Q1 earnings on May 9. Unfortunately, the situation in the COVID-19 vaccines market has changed significantly. Now, we have an oversupply reality.Yet, Novavax still does not have its EUA from the US FDA. Also, we think its revenue visibility for FY22-23 is at risk.Therefore, we revise our rating on NVAX stock from Buy to Sell. Don't catch the falling knives from here.Investment ThesisNovavax, Inc. (NASDAQ:NVAX) is slated to report its Q1 earnings on May 9, ahead of the FDA review of its EUAfor its COVID-19 vaccine. As a result, Novavax investors have been waiting for a considerable amount of time. Unfortunately, much has changed over the last few months since its FQ4 earnings call.In April, Moderna (MRNA) highlighted that the world now has an oversupply of COVID-19 vaccines. It also added that COVAX declined to take up additional options for more vaccines. In its Q1 earnings call, it also highlighted that its FY22 COVID-19 vaccines guidance could be impacted \"if COVAX is unable to confirm demand aligned to their contracted volume in the 2022 calendar year.\"Furthermore, Novavax's key manufacturing partner Serum Institute of India, reportedly suspended the production of COVID-19 vaccines back in December 2021. It highlighted that \"supply outpaced demand amid global vaccine glut.\"As a result, NVAX stock investors should not be surprised that its stock has collapsed 83% from its 2021 highs. We were cautiously optimistic in a previous update, as it had managed to gain several EUAs outside of the US. However, we think the tide has turned significantly for Novavax.Despite the significant battering in its price, we think the time has come for Novavax investors to use any rally in NVAX stock to cut exposure partially or fully.As a result, we revise our rating on NVAX stock from Buy to Sell.NVAX Stock Deserves Its Lower Valuation MultiplesNVAX stock NTM revenue multiples(TIKR)NVAX stock last traded at an NTM revenue multiple of 0.8x. It was well below the valuations of its two leading mRNA counterparts, Moderna and BioNTech (BNTX) stock. We think the bifurcation is justified, given the proven commercial success of its mRNA peers' vaccines. Furthermore, they have several pipelines developed on top of their proven mRNA platforms that should attract more confidence from biotech investors.While Novavax keeps its investors on tenterhooks, Moderna and BioNTech have capitalized on its tardiness and dominated the COVID-19 vaccines market. So even though we recognized that Novavax's vaccine holds tremendous promise, it's simply too little too late.Furthermore, the reality in The African Union and COVAX accentuated the waning demand for COVID-19 vaccines as they dealt with several challenges. Bloomberg reported that these \"lower-income countries left behind in the global rollout are now grappling with a lack of funds, hesitancy, supply-chain obstacles, and other factors that are hampering distribution.\" As a result, \"the vaccine landscape has changed drastically in recent months.\"Notably, Pfizer (PFE) also declined to provide an update on FY23's visibility, despite reiterating its guidance for 2022. Therefore, we believe that the oversupply situation in 2022 would likely drag on further to 2023. As a result, Novavax's estimates for FY22-23 could have significant downside risks.Novavax's Estimates Revised DownwardsNovavax revenue consensus estimates(S&P Capital IQ)Hence, investors shouldn't be surprised that Novavax's revenue estimates have been revised downwards to reflect these uncertainties. The updated consensus estimates suggest the revenue bar that Novavax needs to clear in Q1 is $845.2M, down from March's estimates of $909.08M. However, the Street remains convinced that Novavax's revenue growth could gain momentum from Q2. Therefore, we believe that it's imperative for Novavax to reiterate or raise its previous FY22 guidance of $4.5B to assuage the market.Nevertheless, we believe that the market remains uncertain over its guidance from FY23. As a result, we think the lack of visibility from its mRNA counterparts could continue to hamper NVAX stock momentum moving forward. Moreover, we believe it will be a tall order for management to communicate guidance beyond FY22, given the dynamics in the supply situation surrounding the COVID-19 vaccines.Is NVAX Stock A Buy, Sell, Or Hold?NVAX stock price chart(TradingView)The bull trap in early 2021 proved prescient for investors who sold into that rally and took profit astutely. NVAX stock bagholders are now left with a mess as it broke below a critical support zone ($76) in April 2022. A recovery above that zone will be critical for NVAX stock to regain its support. Otherwise, it is increasingly likely that the stock is currently in free fall to an undetermined support level.Therefore, we think the speculative run on NVAX stock has come to an abrupt end. Accordingly, we revise our rating on NVAX stock from Buy to Sellahead of its Q1 card.","news_type":1},"isVote":1,"tweetType":1,"viewCount":171,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9062320849,"gmtCreate":1652008738881,"gmtModify":1676535012993,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Tesla","listText":"Tesla","text":"Tesla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9062320849","repostId":"1131831539","repostType":4,"repost":{"id":"1131831539","pubTimestamp":1651980653,"share":"https://www.laohu8.com/m/news/1131831539?lang=&edition=full","pubTime":"2022-05-08 11:30","market":"us","language":"en","title":"Tesla: Overvalued By 85.26% And Not A Technology Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1131831539","media":"Seeking Alpha","summary":"SummaryMake no mistake, Tesla is a phenomenal company that has accomplished the unthinkable as it broke through extreme barriers of entry to disrupt the auto industry.Just because Tesla is a successfu","content":"<html><head></head><body><p>Summary</p><ul><li>Make no mistake, Tesla is a phenomenal company that has accomplished the unthinkable as it broke through extreme barriers of entry to disrupt the auto industry.</li><li>Just because Tesla is a successful company that is causing automotive titans to change from combustible engines to EVs doesn&#39;t mean Tesla&#39;s stock is a good investment today.</li><li>100% of gross profit and net income is generated from the automotive sector as Tesla&#39;s other businesses lose money, making them an automobile manufacturing company, not a technology company.</li><li>I compared Tesla&#39;s metrics to the auto industry and big tech and the results are the same, Tesla&#39;s valuation is egregious.</li></ul><p>It&#39;s rare to find companies that have cult-like followings with loyalists willing to pay any price for its stock. The debate regarding Tesla, Inc.&#39;s (NASDAQ:TSLA) valuation continues to be a topic of conversation between the bulls and the bears. Oneside argues that TSLA&#39;s financial growth and future prospects, including FSD, insurance, and robotaxis, justify the current $902.12 billion valuations, while others argue that the current financials and cult-like following have led to a massive overvaluation in TSLA&#39;s stock.</p><p>I tip my hat to Elon Musk, as his accomplishments are second to none. When others called him crazy, Mr. Musk chose one of the hardest industries to compete in, started TSLA from the ground up, went to battle against the auto manufacturers, and succeeded. TSLA is one of the rare success stories that has truly shaped an industry, and the barriers of entry that were overcome are astonishing. TSLA didn&#39;t have the capital, manufacturing, credibility, or the infrastructure that its competitors did, yet they found a way to succeed. If the odds weren&#39;t enough which TSLA faced, they accomplished their goals without a combustible engine and pioneered an entirely new sector within the automotive industry.</p><p>Just because TSLA is a great company, it doesn&#39;t mean TSLA has a great stock, or it isn&#39;t overvalued. I am not bearish on TSLA the company because I believe they still have a long runway of growth ahead of them, but I am bearish on the valuation. Prior to leaving a comment on why I am wrong, please read the article and think about the metrics I am citing; then, I will happily discuss any viewpoints about the analysis.</p><p><b>Tesla Vs. The World In The Automotive Sector</b></p><p>It feels like TSLA vs. the world whenever TSLA is discussed. Discussing who makes a better automobile is a matter of opinion, and everyone is correct because it&#39;s their opinion. If person A thinks TSLA makes the best car and person B thinks Mercedes Benz makes the best car, they are both correct. Debating over this is pointless, so let&#39;s look at the raw numbers.</p><p>TSLA has a larger market cap than the combination ofToyota(TM),Volkswagen(OTCPK:VWAGY),Daimler(OTCPK:DDAIF),BMW(OTCPK:BMWYY),General Motors(GM),Ford(F),Honda(HMC),Ferrari(RACE),Nissan(OTCPK:NSANY),Subaru(OTCPK:FUJHY),Volvo(OTCPK:VOLAF), andMazda(OTCPK:MZDAY). TSLA&#39;s market cap is currently $986.92 billion, while the combination of these 12 companies is $777.41 billion.</p><p><img src=\"https://static.tigerbbs.com/ff930d2442bf282c1bd880cca408eb94\" tg-width=\"640\" tg-height=\"327\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo</p><p>The P/S ratio is often cited to justify the valuation. The combination of TM, VWAGY, DDAIF, BMWYY, GM, F, HMC, RACE, NSANY, FUJHY, VOLAF, and MZDAY has generated $1.38 trillion in revenue over the TTM, putting their P/S at 0.56, while TSLA has generated $62.19 billion in revenue and has a 15.87 P/S.</p><p><img src=\"https://static.tigerbbs.com/c9b9661fde232925a758c38fd2e93f36\" tg-width=\"640\" tg-height=\"330\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo, Seeking Alpha</p><p>As a combined entity, these 12 companies have generated $118.29 billion in net income, while TSLA has produced $8.4 billion.</p><p><img src=\"https://static.tigerbbs.com/d25806eb839eb9ca2b4ef3c24218048c\" tg-width=\"640\" tg-height=\"330\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo, Seeking Alpha</p><p>TSLA is a great company, but its current valuation has become overly inflated. TSLA&#39;s market cap is $209.52 billion larger than these 12 auto manufacturers, yet the combination of the 12 auto manufacturers generates $1.32 trillion more in revenue and $109.89 billion more in net income.</p><p><img src=\"https://static.tigerbbs.com/a1b686de4009ca733ff9651ce0d9fcaf\" tg-width=\"640\" tg-height=\"348\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo, Seeking Alpha</p><p>Looking at the market caps, one would assume that TSLA has a dominant majority over its competitors in auto sales within the U.S. According to the2021 data, TSLA sold 2.02% of all vehicles in the U.S. TSLA&#39;s market cap reflects a level of dominance that is non-existent.</p><p>Realistically, TSLA will have a hard time disrupting the sector further due to the price point of their vehicles. The reality is that, unless TSLA can sell a car that rivals a Honda or Toyota, doubling its market share is going to be a daunting task. It&#39;s just math. TSLA doesn&#39;t have a product for the masses, and while it may continue to grow in the luxury segment, the amount of growth that can be achieved is limited due to the pricing power of the consumer.</p><p><img src=\"https://static.tigerbbs.com/442ffe151dd83bc524785857925f9797\" tg-width=\"640\" tg-height=\"227\" referrerpolicy=\"no-referrer\"/></p><p>www.goodcarbadcar.net</p><p><b>Tesla Isn&#39;t A Technology Company And Shouldn&#39;t Be Valued As One</b></p><p>The valuation rebuttal has always been that TSLA isn&#39;t an automobile company, rather, it&#39;s a technology company.</p><p><img src=\"https://static.tigerbbs.com/bbc9ccb2cb8a0e7d40804db24e183214\" tg-width=\"640\" tg-height=\"341\" referrerpolicy=\"no-referrer\"/></p><p>Tesla</p><p>Page 23 ofTSLA&#39;s Q1 2022 slide deck from their earnings call is their statement of operations. Once again, 100% of TSLA&#39;s gross profit and net income are derived from automobiles. Energy generation and storage lose money as it generates $616 million in revenue while the cost of this revenue is $688 million. The same goes for Services and others, as this segment generates $1.279 billion in revenue while the cost of this revenue is $1.286 billion. This doesn&#39;t even factor in operating expenses.</p><p>TSLA manufacturers state of the art automobiles, but this doesn&#39;t classify them as a technology company, nor should they be classified as one. Since this is always the rebuttal and technology companies trade at larger earnings multiples, I will compare TSLA to Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Alphabet (GOOG) (GOOGL), and Meta Platforms (FB) and illustrate why TSLA is still drastically overvalued if the market was still to provide it with a tech multiple.</p><p>Prior to the comparisons, I want to frame the analysis by providing each company&#39;s market cap:</p><ul><li>AAPL $2.69 Trillion</li><li>MSFT $2.17 Trillion</li><li>GOOGL $1.62 Trillion</li><li>AMZN $1.28 Trillion</li><li>TSLA $986.92 Billion</li><li>FB $604.62 Billion</li></ul><p>I am going to start with growth because this is always the key metric bulls point out. Since the close of 2018, which is 3.25 fiscal years, TSLA has grown its revenue from $21.46 billion to $62.19 billion.</p><p>This is absolutely remarkable, but it doesn&#39;t place TSLA in the upper epsilon of technology companies. Over the same period, FB grew its revenue by $63.83 billion, which is more than what TSLA produced in the TTM. FB grew its revenue by more than what TSLA produces and generates just about double the revenue ($119.67 billion), yet TSLA has a larger market cap. For everyone who has used growth as their investment premise, FB having a market cap that&#39;s $382.30 less than TSLA nullifies that aspect of the bull thesis. AMZN&#39;s market cap is only $294.33 billion larger than TSLA, yet they generated $477.75 billion in revenue and grew their revenue by $341.76 billion in this period. Using revenue growth for TSLA doesn&#39;t support the valuation.</p><p><img src=\"https://static.tigerbbs.com/3c0fbd4eb93f026c4575ee8f77f53e4b\" tg-width=\"640\" tg-height=\"396\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo, Seeking Alpha</p><p>Next, I will turn to profits because, at the end of the day, businesses are in the business of making money. Once again, TSLA has done a fantastic job of monetizing its business and, in 3.25 short years, has gone from losing -$976 million to make $8.4 billion in the TTM for an increase of $9.38 billion. FB has produced $37.34 billion in profit in the TTM, and its net income grew by $15.23 billion over this period. Using growth doesn&#39;t support the valuation when FB has a market cap that&#39;s $382.30 less than TSLA and grew its profits in this period by almost double what TSLA has generated in the TTM.</p><p><img src=\"https://static.tigerbbs.com/c9716477607711ee0b6d4f77eb24c890\" tg-width=\"640\" tg-height=\"382\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo, Seeking Alpha</p><p>The new metric bulls are using in their thesis is TSLA&#39;s free cash flow (FCF). Once again, TSLA has done an excellent job, going from -$221 million of FCF in 2018 to $6.93 billion of FCF in the TTM. Many companies would love to grow their annual FCF by $7.15 billion over a 3.25-year period, and this should be applauded.</p><p>Let&#39;s look at FB once again, since TSLA&#39;s valuation isn&#39;t based on its core segment as an automobile manufacturer. FB has grown its FCF over the previous 3.25 years by $23.45 billion, more than 3x TSLA&#39;s growth, and has generated $39.81 billion of FCF in the TTM. FB generated roughly 5.75x more FCF than TSLA and grew its FCF by more than 3x what TSLA produces, yet FB has a market cap that&#39;s almost $400 billion less than TSLA. Growth within the financials does not support TSLA&#39;s valuation, which is a breath away from $1 trillion.</p><p><img src=\"https://static.tigerbbs.com/902a7074eda9e8f2f2765e0833423d2c\" tg-width=\"640\" tg-height=\"373\" referrerpolicy=\"no-referrer\"/></p><p>Steven Fiorillo, Seeking Alpha</p><p>Today you&#39;re paying a 113.81 P/E for TSLA. Paying a larger multiple for a company that&#39;s growing its earnings quickly is normal, but TSLA isn&#39;t growing by larger amounts than FB, and FB trades at a 16.66 P/E. I have seen TSLA bulls justify the P/E because of TSLA&#39;s growth factor, but this doesn&#39;t hold up when FB has grown by larger amounts from larger starting positions and has a P/E that&#39;s a fraction of TSLA. Look at AAPL, which is the largest company in the world. AAPL has grown its net income by $56.25 billion and its FCF by $52.3 billion over the past 3.25 years, and its P/E is 26.78. People are blindly paying any multiple the market places on TSLA.</p><p><img src=\"https://static.tigerbbs.com/75168f6e39ced721cf0c53d78481a983\" tg-width=\"614\" tg-height=\"335\" referrerpolicy=\"no-referrer\"/>TSLA is trading at a 15.38 P/S. The justification for this multiple is difficult to defend while AMZN trades at a P/S of 11.31. AMZN&#39;s revenue grew by $341.76 billion over the past 3.25 years while TSLA grew their revenue by $40.73 billion. Instead of an absolute basis, looking at this from a percentage aspect, TSLA grew its revenue by 189.78%, while AMZN&#39;s grew by 251.32%. The P/S ratio is not a supporting valuation metric as TSLA is trading at a larger multiple than AMZN yet produced $301.03 billion less in revenue growth compared to AMZN. At the very least, TSLA should trade at a lower P/S multiple than AMZN considering their revenue growth was a fraction of AMZN&#39;s.</p><p><img src=\"https://static.tigerbbs.com/aad00a6c490808962705a1a2dae45cfe\" tg-width=\"608\" tg-height=\"338\" referrerpolicy=\"no-referrer\"/>TSLA has done an excellent job monetizing its revenue, delivering exceptional margins, and generating FCF. Now that TSLA is generating billions in FCF, it&#39;s been inserted into the bull thesis. FCF is a measure of profitability that excludes the non-cash expenses of the income statement and includes spending on equipment and assets as well as changes in working capital from the balance sheet. FCF could be the most underrated and most important financial metric to look at, as this is the pool of capital that companies can utilize to repay debt, pay dividends, buy back shares, make acquisitions, or reinvest in the business.</p><p>Every investment is the present value of all future cash flow. This is why investors look at the price to FCF valuation. Investors want to pay the cheapest multiple for a company&#39;s FCF. Today, you&#39;re paying 142.52x TSLA&#39;s FCF. Going back to the FCF section, TSLA grew its FCF by $7.15 billion over the past 3.25 years. FB generated $23.45 billion of FCF in this period, which is 3x the amount TSLA grew, yet FB is trading at a 15.19x multiple on price to FCF.</p><p>Why on earth would you want to pay 142.52x for TSLA&#39;s FCF when you could pay 15.19x for FB, which is growing their FCF by more than 3x the amount that TSLA is growing by? How about AAPL? AAPL grew its FCF by $52.3 billion and trades at a 25.4x price to FCF. If I exclude FB for a moment, should TSLA trade at a larger FCF multiple than GOOGL, which has grown its FCF by $46.15 billion over the past 3.25 years? My answer is no because there is no guarantee that TSLA will ever generate $46.15 billion in annual FCF, let alone the $68.99 billion in FCF that GOOGL generates.</p><p>So what is a fair price to FCF multiple for TSLA? I don&#39;t believe TSLA has earned the right to trade at the same multiples as the rest of big tech considering the levels of FCF they produce. If I stick with the methodology that FB is egregiously undervalued, then TSLA should trade above 15.19x its FCF but lower than the 23.42x multiple GOOGL trades at.</p><p>I don&#39;t want to be overly bearish, so I will place a 21x multiple on TSLA&#39;s FCF, which is more than fair considering big tech metrics. A 21x multiple on TSLA&#39;s FCF puts its market cap at $145.43 billion, which is -85.26% from its current market cap of $986.92 billion. It&#39;s just math, and if TSLA is going to be valued as a technology company, it needs to be compared to the technology companies with similar market caps.</p><p>At the very least, there isn&#39;t a single reason why TSLA&#39;s market cap is larger than FB&#39;s. There isn&#39;t a single metric that TSLA beats FB in. Based on FB&#39;s valuation, if TSLA traded at the same FCF multiple, it would have a market cap of $105.19 billion.</p><p><img src=\"https://static.tigerbbs.com/b81a61d60d9ec098276569cc4a501da0\" tg-width=\"627\" tg-height=\"341\" referrerpolicy=\"no-referrer\"/>TSLA has a gross profit margin of 27.1% ($16.85b / $62.19b) and a profit margin of 13.51% ($8.4b / $62.19b). FB has a gross profit margin of 80.34% ($96.14b / $119.67b) and a profit margin of 31.2% ($37.34b / $119.67b). FB has much wider margins and is growing its revenue by larger amounts. This reinforces my methodology as to why TSLA is grossly overvalued. GOOGL has a gross profit margin of 56.93% ($153.9b / $270.33b) and a profit margin of 27.57% ($74.54b / $270.33b).</p><p>The chances are incredibly slim that TSLA can double its profit margin to be within striking distance of GOOGL&#39;s. TSLA should not trade at a larger FCF, P/E, or P/S multiple than FB or GOOGL. While the market would indicate that I am wrong today, eventually, the hype will wear off, and TSLA will trade at a realistic valuation.</p><p><b>TSLA&#39;s Future Catalysts Have A Long Way To Go Before Impacting Its Bottom Line</b></p><p>There are three main catalysts people discuss, which include insurance, robotaxis, and FSD.TSLA offers insurance using real-time driving behavior. This is currently available to all Model S, Model 3, Model X, and Model Y owners. The catch is that it&#39;s only available in Arizona, Colorado, Illinois, Ohio, Oregon, Texas, and Virginia as of now.</p><p>TSLA uses a safety rating score to determine the monthly premium for its vehicles. At the largest premium of $130/mo, this would be $1,560 per year. If TSLA converted 100% of their U.S sales in 2021 as an insurance customer, which I think could be possible if TSLA insurance was available in every state, it would have generated $471.12 million in revenue.</p><p>We have no idea what the margins would have been, but if the margin was 50%, it would have been an additional $235.56 million in net income in 2021. While this is nothing to sneeze at, an additional $235.56 million in net income hardly moves the needle. This could be a $1 billion top-line revenue segment in the future, but with availability in only 7 states, insurance&#39;s $1 billion revenue mark is a long way away.</p><p><img src=\"https://static.tigerbbs.com/e86de6232b9abf7cee46a9607eb09741\" tg-width=\"640\" tg-height=\"326\" referrerpolicy=\"no-referrer\"/></p><p>Tesla</p><p>Next,FSD, for which TSLA has created two subscription models, a $99/mo price point and a $199/mo price point. The problem with FSD is that it doesn&#39;t make the vehicle fully autonomous, and you still need a driver to be attentive and alert. While I am not arguing that TSLA&#39;s FSD isn&#39;t leaps and bounds ahead of the competition, the problem is that it&#39;s not exactly a self-driving car.</p><p>The questions around legality and where you can use it pop into my head, and how many of TSLA&#39;s drivers opt for this upgrade. Until there is clear legislation and the technology advances to where vehicles can fully drive a person from point A to B while that person takes a nap or reads, I have a hard time believing enough TSLA owners will spend the extra $199/mo on FSD. If there is somewhere where TSLA produces the numbers about how many owners opt for this package, please let me know, and I will crunch the numbers.</p><p>Which Features Come With My Subscription?</p><blockquote>The FSD capability features you receive are based on your configuration and location. Not all features are available in all markets, and features are subject to change.Learn more about Autopilot and Full Self-Driving capability features.</blockquote><blockquote><i>Note: These features are designed to become more capable over time; however the currently enabled features do not make the vehicle autonomous. The currently enabled features require a fully attentive driver, who has their hands on the wheel and is prepared to take over at any moment.</i></blockquote><p>The last catalyst is Robotaxis which many have commented on in my articles before. We&#39;re so far off on Robotaxis that this can&#39;t be considered in TSLA&#39;s upcoming revenue. I would think major legislation would be needed for Robotaxis to exist, and there is no telling how many years away we are from this.</p><p>Also, what is the percentage of TSLA owners that would actually allow their vehicle to be used as a Robotaxi? Depending on what the profitability is, I can see people buying TSLAs to enroll them in this program, but, once again, we need to see the economics behind it. I know I am just one opinion, but I would never enroll one of my cars into a robotaxi program because I don&#39;t want other people that I don&#39;t know in my car. I would think there are many others that have similar viewpoints.</p><p>The real upcoming catalysts are future revenue growth and entering the Chinese market. In 2021 TSLA grew its YoY revenue by 70.67%, and their off to a great start after Q1 2022. Only time will tell what type of growth rate TSLA can maintain, but too many people are assuming that TSLA will obliterate the competition. Over the next several years, we could see TSLA&#39;s growth rate become significantly reduced as more luxury operators put EVs on the road.</p><p>At TSLA&#39;s current margins, they would need to increase their revenue by 444.55% to $276.47 billion to produce the same amount of net income ($37.34b) that FB produces today at their current 13.51% profit margin. Maybe TSLA can get there in the future, but why should TSLA be valued at almost $1 trillion today, considering not a single metric of theirs is similar to FB or GOOGL, and TSLA&#39;s growth across any of the sectors isn&#39;t larger than FB or GOOGL?</p><p><b>Tesla Continues To Dilute Shareholders, And Almost No Shareholders Care</b></p><p>Dilution kills shareholder value. Look, I am a shareholder of TSLA, and I hate that my shares continue to be diluted. These numbers are split-adjusted that I am using. Over the past decade,TSLA has diluted its shares by 80.93%. This is horrible compared to big tech, yet investors can&#39;t buy enough TSLA shares. TSLA finished 2012 with 572.6 million shares and, as of its last filing, had increased its outstanding shares to 1.036 billion shares.</p><p>This is the equivalent of me taking a pizza, and instead of giving you a slice, cutting another 6.5 slices, then giving you one. The pizza represents TSLA, the company, and they basically turned an 8-slice pie into a 14.5-slice pie, reducing shareholder&#39;s ownership and the amount of equity, revenue, and EPS our shares represent.</p><p>If you want to see what a true shepherd of shareholder value looks like, turn to AAPL. In 2012 AAPL had 26.3 billion shares outstanding. Over the past decade, AAPL has repurchased 10.09 billion shares, reducing its outstanding shares by 38.37%. Every quarter, AAPL is buying back shares and increasing the ownership its shares represent. TSLA, on the other hand, continues to dilute shareholders by increasing shares YOY.</p><p><b>I Could Be Completely Wrong, And Tesla Could Continue Growing At These Rates</b></p><p>TSLA&#39;s vehicle deliveries continue to outpace its growing production. YoY TSLA&#39;s deliveries increased by 68% in Q1, adding 125,171 delivered vehicles to its customers. TSLA just began Model Y deliveries from the Austin facility, and production at the Gigafactory in Berlin started in March of 2022. TSLA&#39;s Shanghai facility had strong production rates prior to the spike in COVID that resulted in temporary shutdowns. TSLA isn&#39;t just focusing on the U.S, they have Europe and China in their sights.</p><p>EVs accounted for 488,000 sales in the U.S for 2021, and the previous projection was that EVs would account for 670,000 units sold in 2022. Oil has hovered around $100 per barrel and could render the previous projections of 37% increased EV sales domestically for 2022 conservative. TSLA is in a prime position to capitalize on this trend. In 2021 TSLA vehicles accounted for 61.89% of EVs sold in the U.S (301,998 / 488,000).</p><p>Hypothetically, if the previous projection of 670,000 EV sales for 2022 is accurate and TSLA maintains its current margin, they would sell 414,628 vehicles throughout the U.S in 2022. If gas prices do alter the decision-making process when deciding between a combustible engine or an EV, then TSLA could continue surprising the market with QoQ earnings beats.</p><p>The U.S has a national goal of reaching 50% of domestic auto sales coming from EVs. In 2021, EVs accounted for 3.26% of total sales in the U.S auto market. Based on U.S auto sales in 2021, annual EV sales would need to grow by 6,989,403 to reach a 50% EV to combustible engine ratio. Hypothetically if U.S auto sales stayed flat but EVs reached 50% of the market in 2030 they would sell 7,477,403 vehicles. If TSLA&#39;s dominance in the EV sector was to drop from 61.89% to 15% due to increased competition, they would generate 1,121,610 in sales compared to 301,998 in 2021. When you add in Europe and China, TSLA certainly has the ability to become a top auto manufacturer by sales next decade.</p><p>Bulls aren&#39;t incorrect to be excited about TSLA. The world is moving toward EVs, and TSLA is the crème de la crème. As I said in the beginning, I am bullish about TSLA&#39;s future prospects, but I think the valuation today is overinflated. Nobody can predict the future, but I have no doubt that TSLA will continue to grow its sales YoY.</p><p>The question becomes, how much growth will they be able to achieve YoY? In 2021, TM generated $226.48 billion of revenue and, based on the future of EVs, TSLA certainly could achieve this level of revenue in the future. Based on TSLA&#39;s current 13.51% profit margin, if they achieved TM&#39;s level of revenue, they would generate $30.59 billion of net income, which would definitely make today&#39;s valuation look more realistic.</p><p><img src=\"https://static.tigerbbs.com/93c9176fa9bebc2c940e038cafd23229\" tg-width=\"603\" tg-height=\"631\" referrerpolicy=\"no-referrer\"/></p><p>Tesla</p><p><b>Conclusion</b></p><p>You&#39;re probably wondering how I can be a shareholder and be a bear on TSLA&#39;s valuation at the same time. It&#39;s simple; my wife bought shares of TSLA, which makes me a shareholder. My stance has always been bullish on the company and bearish on the valuation. What Elon Musk and the team at TSLA has accomplished is astonishing, and they deserve nothing but respect.</p><p>Keep in mind a company and a company&#39;s stock are two separate things. TSLA continues to dilute shareholders, and they and the market are valuing TSLA as if it&#39;s FB or GOOGL. TSLA is not a technology company; it&#39;s an automobile company, as the automotive segments drive 100% of its gross revenue and net income.</p><p>TSLA is trading at a P/E of 113.81, a P/S of 15.38, and a 142.52x multiple on its FCF. The numbers are drastically inflated as TSLA has no business trading at a larger P/S multiple than AMZN, which trades at 11.31 P/S when it has grown its revenue by $341.76 billion over the previous 3.25 years compared to TSLA&#39;s $40.73 billion of revenue growth. TSLA has generated $6.93 billion in FCF over the TTM, while Mr. Market has placed a 142.52x multiple on TSLA due to $7.15 billion FCF growth over the past 3.25 years. FB trades at a 15.19x FCF multiple while growing FCF by $23.45 billion over this period which is more than 3x what TSLA has generated in the TTM.</p><p>With FB trading at 15.19x FCF, GOOGL at 23.42x FCF, and AAPL at 25.4x FCF, it&#39;s hard to justify any number above 20x for TSLA. I think a 21x FCF multiple is generous and that places TSLA at a market cap of $145.43 billion, which is -85.26% from its current market cap of $986.92 billion.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla: Overvalued By 85.26% And Not A Technology Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla: Overvalued By 85.26% And Not A Technology Company\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-08 11:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4507535-tesla-overvalued-by-85-26-percent-and-not-a-technology-company><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SummaryMake no mistake, Tesla is a phenomenal company that has accomplished the unthinkable as it broke through extreme barriers of entry to disrupt the auto industry.Just because Tesla is a ...</p>\n\n<a href=\"https://seekingalpha.com/article/4507535-tesla-overvalued-by-85-26-percent-and-not-a-technology-company\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://seekingalpha.com/article/4507535-tesla-overvalued-by-85-26-percent-and-not-a-technology-company","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1131831539","content_text":"SummaryMake no mistake, Tesla is a phenomenal company that has accomplished the unthinkable as it broke through extreme barriers of entry to disrupt the auto industry.Just because Tesla is a successful company that is causing automotive titans to change from combustible engines to EVs doesn't mean Tesla's stock is a good investment today.100% of gross profit and net income is generated from the automotive sector as Tesla's other businesses lose money, making them an automobile manufacturing company, not a technology company.I compared Tesla's metrics to the auto industry and big tech and the results are the same, Tesla's valuation is egregious.It's rare to find companies that have cult-like followings with loyalists willing to pay any price for its stock. The debate regarding Tesla, Inc.'s (NASDAQ:TSLA) valuation continues to be a topic of conversation between the bulls and the bears. Oneside argues that TSLA's financial growth and future prospects, including FSD, insurance, and robotaxis, justify the current $902.12 billion valuations, while others argue that the current financials and cult-like following have led to a massive overvaluation in TSLA's stock.I tip my hat to Elon Musk, as his accomplishments are second to none. When others called him crazy, Mr. Musk chose one of the hardest industries to compete in, started TSLA from the ground up, went to battle against the auto manufacturers, and succeeded. TSLA is one of the rare success stories that has truly shaped an industry, and the barriers of entry that were overcome are astonishing. TSLA didn't have the capital, manufacturing, credibility, or the infrastructure that its competitors did, yet they found a way to succeed. If the odds weren't enough which TSLA faced, they accomplished their goals without a combustible engine and pioneered an entirely new sector within the automotive industry.Just because TSLA is a great company, it doesn't mean TSLA has a great stock, or it isn't overvalued. I am not bearish on TSLA the company because I believe they still have a long runway of growth ahead of them, but I am bearish on the valuation. Prior to leaving a comment on why I am wrong, please read the article and think about the metrics I am citing; then, I will happily discuss any viewpoints about the analysis.Tesla Vs. The World In The Automotive SectorIt feels like TSLA vs. the world whenever TSLA is discussed. Discussing who makes a better automobile is a matter of opinion, and everyone is correct because it's their opinion. If person A thinks TSLA makes the best car and person B thinks Mercedes Benz makes the best car, they are both correct. Debating over this is pointless, so let's look at the raw numbers.TSLA has a larger market cap than the combination ofToyota(TM),Volkswagen(OTCPK:VWAGY),Daimler(OTCPK:DDAIF),BMW(OTCPK:BMWYY),General Motors(GM),Ford(F),Honda(HMC),Ferrari(RACE),Nissan(OTCPK:NSANY),Subaru(OTCPK:FUJHY),Volvo(OTCPK:VOLAF), andMazda(OTCPK:MZDAY). TSLA's market cap is currently $986.92 billion, while the combination of these 12 companies is $777.41 billion.Steven FiorilloThe P/S ratio is often cited to justify the valuation. The combination of TM, VWAGY, DDAIF, BMWYY, GM, F, HMC, RACE, NSANY, FUJHY, VOLAF, and MZDAY has generated $1.38 trillion in revenue over the TTM, putting their P/S at 0.56, while TSLA has generated $62.19 billion in revenue and has a 15.87 P/S.Steven Fiorillo, Seeking AlphaAs a combined entity, these 12 companies have generated $118.29 billion in net income, while TSLA has produced $8.4 billion.Steven Fiorillo, Seeking AlphaTSLA is a great company, but its current valuation has become overly inflated. TSLA's market cap is $209.52 billion larger than these 12 auto manufacturers, yet the combination of the 12 auto manufacturers generates $1.32 trillion more in revenue and $109.89 billion more in net income.Steven Fiorillo, Seeking AlphaLooking at the market caps, one would assume that TSLA has a dominant majority over its competitors in auto sales within the U.S. According to the2021 data, TSLA sold 2.02% of all vehicles in the U.S. TSLA's market cap reflects a level of dominance that is non-existent.Realistically, TSLA will have a hard time disrupting the sector further due to the price point of their vehicles. The reality is that, unless TSLA can sell a car that rivals a Honda or Toyota, doubling its market share is going to be a daunting task. It's just math. TSLA doesn't have a product for the masses, and while it may continue to grow in the luxury segment, the amount of growth that can be achieved is limited due to the pricing power of the consumer.www.goodcarbadcar.netTesla Isn't A Technology Company And Shouldn't Be Valued As OneThe valuation rebuttal has always been that TSLA isn't an automobile company, rather, it's a technology company.TeslaPage 23 ofTSLA's Q1 2022 slide deck from their earnings call is their statement of operations. Once again, 100% of TSLA's gross profit and net income are derived from automobiles. Energy generation and storage lose money as it generates $616 million in revenue while the cost of this revenue is $688 million. The same goes for Services and others, as this segment generates $1.279 billion in revenue while the cost of this revenue is $1.286 billion. This doesn't even factor in operating expenses.TSLA manufacturers state of the art automobiles, but this doesn't classify them as a technology company, nor should they be classified as one. Since this is always the rebuttal and technology companies trade at larger earnings multiples, I will compare TSLA to Apple (AAPL), Microsoft (MSFT), Amazon (AMZN), Alphabet (GOOG) (GOOGL), and Meta Platforms (FB) and illustrate why TSLA is still drastically overvalued if the market was still to provide it with a tech multiple.Prior to the comparisons, I want to frame the analysis by providing each company's market cap:AAPL $2.69 TrillionMSFT $2.17 TrillionGOOGL $1.62 TrillionAMZN $1.28 TrillionTSLA $986.92 BillionFB $604.62 BillionI am going to start with growth because this is always the key metric bulls point out. Since the close of 2018, which is 3.25 fiscal years, TSLA has grown its revenue from $21.46 billion to $62.19 billion.This is absolutely remarkable, but it doesn't place TSLA in the upper epsilon of technology companies. Over the same period, FB grew its revenue by $63.83 billion, which is more than what TSLA produced in the TTM. FB grew its revenue by more than what TSLA produces and generates just about double the revenue ($119.67 billion), yet TSLA has a larger market cap. For everyone who has used growth as their investment premise, FB having a market cap that's $382.30 less than TSLA nullifies that aspect of the bull thesis. AMZN's market cap is only $294.33 billion larger than TSLA, yet they generated $477.75 billion in revenue and grew their revenue by $341.76 billion in this period. Using revenue growth for TSLA doesn't support the valuation.Steven Fiorillo, Seeking AlphaNext, I will turn to profits because, at the end of the day, businesses are in the business of making money. Once again, TSLA has done a fantastic job of monetizing its business and, in 3.25 short years, has gone from losing -$976 million to make $8.4 billion in the TTM for an increase of $9.38 billion. FB has produced $37.34 billion in profit in the TTM, and its net income grew by $15.23 billion over this period. Using growth doesn't support the valuation when FB has a market cap that's $382.30 less than TSLA and grew its profits in this period by almost double what TSLA has generated in the TTM.Steven Fiorillo, Seeking AlphaThe new metric bulls are using in their thesis is TSLA's free cash flow (FCF). Once again, TSLA has done an excellent job, going from -$221 million of FCF in 2018 to $6.93 billion of FCF in the TTM. Many companies would love to grow their annual FCF by $7.15 billion over a 3.25-year period, and this should be applauded.Let's look at FB once again, since TSLA's valuation isn't based on its core segment as an automobile manufacturer. FB has grown its FCF over the previous 3.25 years by $23.45 billion, more than 3x TSLA's growth, and has generated $39.81 billion of FCF in the TTM. FB generated roughly 5.75x more FCF than TSLA and grew its FCF by more than 3x what TSLA produces, yet FB has a market cap that's almost $400 billion less than TSLA. Growth within the financials does not support TSLA's valuation, which is a breath away from $1 trillion.Steven Fiorillo, Seeking AlphaToday you're paying a 113.81 P/E for TSLA. Paying a larger multiple for a company that's growing its earnings quickly is normal, but TSLA isn't growing by larger amounts than FB, and FB trades at a 16.66 P/E. I have seen TSLA bulls justify the P/E because of TSLA's growth factor, but this doesn't hold up when FB has grown by larger amounts from larger starting positions and has a P/E that's a fraction of TSLA. Look at AAPL, which is the largest company in the world. AAPL has grown its net income by $56.25 billion and its FCF by $52.3 billion over the past 3.25 years, and its P/E is 26.78. People are blindly paying any multiple the market places on TSLA.TSLA is trading at a 15.38 P/S. The justification for this multiple is difficult to defend while AMZN trades at a P/S of 11.31. AMZN's revenue grew by $341.76 billion over the past 3.25 years while TSLA grew their revenue by $40.73 billion. Instead of an absolute basis, looking at this from a percentage aspect, TSLA grew its revenue by 189.78%, while AMZN's grew by 251.32%. The P/S ratio is not a supporting valuation metric as TSLA is trading at a larger multiple than AMZN yet produced $301.03 billion less in revenue growth compared to AMZN. At the very least, TSLA should trade at a lower P/S multiple than AMZN considering their revenue growth was a fraction of AMZN's.TSLA has done an excellent job monetizing its revenue, delivering exceptional margins, and generating FCF. Now that TSLA is generating billions in FCF, it's been inserted into the bull thesis. FCF is a measure of profitability that excludes the non-cash expenses of the income statement and includes spending on equipment and assets as well as changes in working capital from the balance sheet. FCF could be the most underrated and most important financial metric to look at, as this is the pool of capital that companies can utilize to repay debt, pay dividends, buy back shares, make acquisitions, or reinvest in the business.Every investment is the present value of all future cash flow. This is why investors look at the price to FCF valuation. Investors want to pay the cheapest multiple for a company's FCF. Today, you're paying 142.52x TSLA's FCF. Going back to the FCF section, TSLA grew its FCF by $7.15 billion over the past 3.25 years. FB generated $23.45 billion of FCF in this period, which is 3x the amount TSLA grew, yet FB is trading at a 15.19x multiple on price to FCF.Why on earth would you want to pay 142.52x for TSLA's FCF when you could pay 15.19x for FB, which is growing their FCF by more than 3x the amount that TSLA is growing by? How about AAPL? AAPL grew its FCF by $52.3 billion and trades at a 25.4x price to FCF. If I exclude FB for a moment, should TSLA trade at a larger FCF multiple than GOOGL, which has grown its FCF by $46.15 billion over the past 3.25 years? My answer is no because there is no guarantee that TSLA will ever generate $46.15 billion in annual FCF, let alone the $68.99 billion in FCF that GOOGL generates.So what is a fair price to FCF multiple for TSLA? I don't believe TSLA has earned the right to trade at the same multiples as the rest of big tech considering the levels of FCF they produce. If I stick with the methodology that FB is egregiously undervalued, then TSLA should trade above 15.19x its FCF but lower than the 23.42x multiple GOOGL trades at.I don't want to be overly bearish, so I will place a 21x multiple on TSLA's FCF, which is more than fair considering big tech metrics. A 21x multiple on TSLA's FCF puts its market cap at $145.43 billion, which is -85.26% from its current market cap of $986.92 billion. It's just math, and if TSLA is going to be valued as a technology company, it needs to be compared to the technology companies with similar market caps.At the very least, there isn't a single reason why TSLA's market cap is larger than FB's. There isn't a single metric that TSLA beats FB in. Based on FB's valuation, if TSLA traded at the same FCF multiple, it would have a market cap of $105.19 billion.TSLA has a gross profit margin of 27.1% ($16.85b / $62.19b) and a profit margin of 13.51% ($8.4b / $62.19b). FB has a gross profit margin of 80.34% ($96.14b / $119.67b) and a profit margin of 31.2% ($37.34b / $119.67b). FB has much wider margins and is growing its revenue by larger amounts. This reinforces my methodology as to why TSLA is grossly overvalued. GOOGL has a gross profit margin of 56.93% ($153.9b / $270.33b) and a profit margin of 27.57% ($74.54b / $270.33b).The chances are incredibly slim that TSLA can double its profit margin to be within striking distance of GOOGL's. TSLA should not trade at a larger FCF, P/E, or P/S multiple than FB or GOOGL. While the market would indicate that I am wrong today, eventually, the hype will wear off, and TSLA will trade at a realistic valuation.TSLA's Future Catalysts Have A Long Way To Go Before Impacting Its Bottom LineThere are three main catalysts people discuss, which include insurance, robotaxis, and FSD.TSLA offers insurance using real-time driving behavior. This is currently available to all Model S, Model 3, Model X, and Model Y owners. The catch is that it's only available in Arizona, Colorado, Illinois, Ohio, Oregon, Texas, and Virginia as of now.TSLA uses a safety rating score to determine the monthly premium for its vehicles. At the largest premium of $130/mo, this would be $1,560 per year. If TSLA converted 100% of their U.S sales in 2021 as an insurance customer, which I think could be possible if TSLA insurance was available in every state, it would have generated $471.12 million in revenue.We have no idea what the margins would have been, but if the margin was 50%, it would have been an additional $235.56 million in net income in 2021. While this is nothing to sneeze at, an additional $235.56 million in net income hardly moves the needle. This could be a $1 billion top-line revenue segment in the future, but with availability in only 7 states, insurance's $1 billion revenue mark is a long way away.TeslaNext,FSD, for which TSLA has created two subscription models, a $99/mo price point and a $199/mo price point. The problem with FSD is that it doesn't make the vehicle fully autonomous, and you still need a driver to be attentive and alert. While I am not arguing that TSLA's FSD isn't leaps and bounds ahead of the competition, the problem is that it's not exactly a self-driving car.The questions around legality and where you can use it pop into my head, and how many of TSLA's drivers opt for this upgrade. Until there is clear legislation and the technology advances to where vehicles can fully drive a person from point A to B while that person takes a nap or reads, I have a hard time believing enough TSLA owners will spend the extra $199/mo on FSD. If there is somewhere where TSLA produces the numbers about how many owners opt for this package, please let me know, and I will crunch the numbers.Which Features Come With My Subscription?The FSD capability features you receive are based on your configuration and location. Not all features are available in all markets, and features are subject to change.Learn more about Autopilot and Full Self-Driving capability features.Note: These features are designed to become more capable over time; however the currently enabled features do not make the vehicle autonomous. The currently enabled features require a fully attentive driver, who has their hands on the wheel and is prepared to take over at any moment.The last catalyst is Robotaxis which many have commented on in my articles before. We're so far off on Robotaxis that this can't be considered in TSLA's upcoming revenue. I would think major legislation would be needed for Robotaxis to exist, and there is no telling how many years away we are from this.Also, what is the percentage of TSLA owners that would actually allow their vehicle to be used as a Robotaxi? Depending on what the profitability is, I can see people buying TSLAs to enroll them in this program, but, once again, we need to see the economics behind it. I know I am just one opinion, but I would never enroll one of my cars into a robotaxi program because I don't want other people that I don't know in my car. I would think there are many others that have similar viewpoints.The real upcoming catalysts are future revenue growth and entering the Chinese market. In 2021 TSLA grew its YoY revenue by 70.67%, and their off to a great start after Q1 2022. Only time will tell what type of growth rate TSLA can maintain, but too many people are assuming that TSLA will obliterate the competition. Over the next several years, we could see TSLA's growth rate become significantly reduced as more luxury operators put EVs on the road.At TSLA's current margins, they would need to increase their revenue by 444.55% to $276.47 billion to produce the same amount of net income ($37.34b) that FB produces today at their current 13.51% profit margin. Maybe TSLA can get there in the future, but why should TSLA be valued at almost $1 trillion today, considering not a single metric of theirs is similar to FB or GOOGL, and TSLA's growth across any of the sectors isn't larger than FB or GOOGL?Tesla Continues To Dilute Shareholders, And Almost No Shareholders CareDilution kills shareholder value. Look, I am a shareholder of TSLA, and I hate that my shares continue to be diluted. These numbers are split-adjusted that I am using. Over the past decade,TSLA has diluted its shares by 80.93%. This is horrible compared to big tech, yet investors can't buy enough TSLA shares. TSLA finished 2012 with 572.6 million shares and, as of its last filing, had increased its outstanding shares to 1.036 billion shares.This is the equivalent of me taking a pizza, and instead of giving you a slice, cutting another 6.5 slices, then giving you one. The pizza represents TSLA, the company, and they basically turned an 8-slice pie into a 14.5-slice pie, reducing shareholder's ownership and the amount of equity, revenue, and EPS our shares represent.If you want to see what a true shepherd of shareholder value looks like, turn to AAPL. In 2012 AAPL had 26.3 billion shares outstanding. Over the past decade, AAPL has repurchased 10.09 billion shares, reducing its outstanding shares by 38.37%. Every quarter, AAPL is buying back shares and increasing the ownership its shares represent. TSLA, on the other hand, continues to dilute shareholders by increasing shares YOY.I Could Be Completely Wrong, And Tesla Could Continue Growing At These RatesTSLA's vehicle deliveries continue to outpace its growing production. YoY TSLA's deliveries increased by 68% in Q1, adding 125,171 delivered vehicles to its customers. TSLA just began Model Y deliveries from the Austin facility, and production at the Gigafactory in Berlin started in March of 2022. TSLA's Shanghai facility had strong production rates prior to the spike in COVID that resulted in temporary shutdowns. TSLA isn't just focusing on the U.S, they have Europe and China in their sights.EVs accounted for 488,000 sales in the U.S for 2021, and the previous projection was that EVs would account for 670,000 units sold in 2022. Oil has hovered around $100 per barrel and could render the previous projections of 37% increased EV sales domestically for 2022 conservative. TSLA is in a prime position to capitalize on this trend. In 2021 TSLA vehicles accounted for 61.89% of EVs sold in the U.S (301,998 / 488,000).Hypothetically, if the previous projection of 670,000 EV sales for 2022 is accurate and TSLA maintains its current margin, they would sell 414,628 vehicles throughout the U.S in 2022. If gas prices do alter the decision-making process when deciding between a combustible engine or an EV, then TSLA could continue surprising the market with QoQ earnings beats.The U.S has a national goal of reaching 50% of domestic auto sales coming from EVs. In 2021, EVs accounted for 3.26% of total sales in the U.S auto market. Based on U.S auto sales in 2021, annual EV sales would need to grow by 6,989,403 to reach a 50% EV to combustible engine ratio. Hypothetically if U.S auto sales stayed flat but EVs reached 50% of the market in 2030 they would sell 7,477,403 vehicles. If TSLA's dominance in the EV sector was to drop from 61.89% to 15% due to increased competition, they would generate 1,121,610 in sales compared to 301,998 in 2021. When you add in Europe and China, TSLA certainly has the ability to become a top auto manufacturer by sales next decade.Bulls aren't incorrect to be excited about TSLA. The world is moving toward EVs, and TSLA is the crème de la crème. As I said in the beginning, I am bullish about TSLA's future prospects, but I think the valuation today is overinflated. Nobody can predict the future, but I have no doubt that TSLA will continue to grow its sales YoY.The question becomes, how much growth will they be able to achieve YoY? In 2021, TM generated $226.48 billion of revenue and, based on the future of EVs, TSLA certainly could achieve this level of revenue in the future. Based on TSLA's current 13.51% profit margin, if they achieved TM's level of revenue, they would generate $30.59 billion of net income, which would definitely make today's valuation look more realistic.TeslaConclusionYou're probably wondering how I can be a shareholder and be a bear on TSLA's valuation at the same time. It's simple; my wife bought shares of TSLA, which makes me a shareholder. My stance has always been bullish on the company and bearish on the valuation. What Elon Musk and the team at TSLA has accomplished is astonishing, and they deserve nothing but respect.Keep in mind a company and a company's stock are two separate things. TSLA continues to dilute shareholders, and they and the market are valuing TSLA as if it's FB or GOOGL. TSLA is not a technology company; it's an automobile company, as the automotive segments drive 100% of its gross revenue and net income.TSLA is trading at a P/E of 113.81, a P/S of 15.38, and a 142.52x multiple on its FCF. The numbers are drastically inflated as TSLA has no business trading at a larger P/S multiple than AMZN, which trades at 11.31 P/S when it has grown its revenue by $341.76 billion over the previous 3.25 years compared to TSLA's $40.73 billion of revenue growth. TSLA has generated $6.93 billion in FCF over the TTM, while Mr. Market has placed a 142.52x multiple on TSLA due to $7.15 billion FCF growth over the past 3.25 years. FB trades at a 15.19x FCF multiple while growing FCF by $23.45 billion over this period which is more than 3x what TSLA has generated in the TTM.With FB trading at 15.19x FCF, GOOGL at 23.42x FCF, and AAPL at 25.4x FCF, it's hard to justify any number above 20x for TSLA. I think a 21x FCF multiple is generous and that places TSLA at a market cap of $145.43 billion, which is -85.26% from its current market cap of $986.92 billion.","news_type":1},"isVote":1,"tweetType":1,"viewCount":101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066418770,"gmtCreate":1651940498390,"gmtModify":1676535001050,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/JCPI\">$JPMorgan Inflation Managed Bond ETF(JCPI)$</a>sharing","listText":"<a href=\"https://ttm.financial/S/JCPI\">$JPMorgan Inflation Managed Bond ETF(JCPI)$</a>sharing","text":"$JPMorgan Inflation Managed Bond ETF(JCPI)$sharing","images":[{"img":"https://community-static.tradeup.com/news/e260eabcfe30d011f531b1ee73e512ac","width":"1080","height":"2431"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066418770","isVote":1,"tweetType":1,"viewCount":381,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066411258,"gmtCreate":1651940176274,"gmtModify":1676535001023,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Sharing&nbsp;","listText":"Sharing&nbsp;","text":"Sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066411258","repostId":"9066994743","repostType":1,"repost":{"id":9066994743,"gmtCreate":1651834130520,"gmtModify":1676534980410,"author":{"id":"3527667668165440","authorId":"3527667668165440","name":"Capital_Insights","avatar":"https://static.tigerbbs.com/cfdc66fff48bb2b9e2d328ac5eb33100","crmLevel":1,"crmLevelSwitch":0},"themes":[],"title":"Why Market Plummeted? Joining the Vote of 8 Biggest Factors!","htmlText":"On Thursday, the major indexes of US stocks plunged,&nbsp;the <a target=\"_blank\" href=\"https://laohu8.com/S/.IXIC\">$NASDAQ(.IXIC)$</a> dropped the most since 2020.&nbsp;U.S. stocks lost&nbsp;$100 billion overnight, with&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/VIX\">$Cboe Volatility Index(VIX)$</a> rose by&nbsp;22%, and <a target=\"_blank\" href=\"https://laohu8.com/S/UVIX\">$2x Long VIX Futures ETF(UVIX)$</a> rose 37%. Last time we&nbsp;saw&nbsp;such a huge decline was when the COVID-19 hit the USA in 2020. The figure below shows the 5 largest declines of <a target=\"_blank\" href=\"https://laohu8.com/S/.IXIC\">$NASDAQ(.IXIC)$</a> in the past 2&nbsp;years. The explanations of the reasons for the sharp decline of US stocks includes the Non-farm&nbsp;payroll&nbsp;jobs data lower than","listText":"On Thursday, the major indexes of US stocks plunged,&nbsp;the <a target=\"_blank\" href=\"https://laohu8.com/S/.IXIC\">$NASDAQ(.IXIC)$</a> dropped the most since 2020.&nbsp;U.S. stocks lost&nbsp;$100 billion overnight, with&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/VIX\">$Cboe Volatility Index(VIX)$</a> rose by&nbsp;22%, and <a target=\"_blank\" href=\"https://laohu8.com/S/UVIX\">$2x Long VIX Futures ETF(UVIX)$</a> rose 37%. Last time we&nbsp;saw&nbsp;such a huge decline was when the COVID-19 hit the USA in 2020. The figure below shows the 5 largest declines of <a target=\"_blank\" href=\"https://laohu8.com/S/.IXIC\">$NASDAQ(.IXIC)$</a> in the past 2&nbsp;years. The explanations of the reasons for the sharp decline of US stocks includes the Non-farm&nbsp;payroll&nbsp;jobs data lower than","text":"On Thursday, the major indexes of US stocks plunged, the $NASDAQ(.IXIC)$ dropped the most since 2020. U.S. stocks lost $100 billion overnight, with $Cboe Volatility Index(VIX)$ rose by 22%, and $2x Long VIX Futures ETF(UVIX)$ rose 37%. Last time we saw such a huge decline was when the COVID-19 hit the USA in 2020. The figure below shows the 5 largest declines of $NASDAQ(.IXIC)$ in the past 2 years. The explanations of the reasons for the sharp decline of US stocks includes the Non-farm payroll jobs data lower than","images":[{"img":"https://community-static.tradeup.com/news/e37f534a843c9d44dfc9bf301c4b042a","width":"782","height":"478"},{"img":"https://community-static.tradeup.com/news/f576248c13464066f65a4d317e6ff015","width":"741","height":"372"},{"img":"https://community-static.tradeup.com/news/bea0cba3110aff9375f3cb998bed5817","width":"594","height":"420"}],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066994743","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":7,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066411806,"gmtCreate":1651940090305,"gmtModify":1676535001013,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://community-static.tradeup.com/news/b976dc2bc887ab686c71c94f2e7afbfd","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066411806","isVote":1,"tweetType":1,"viewCount":458,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066960761,"gmtCreate":1651839922153,"gmtModify":1676534981339,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066960761","repostId":"2233376983","repostType":4,"repost":{"id":"2233376983","pubTimestamp":1651835393,"share":"https://www.laohu8.com/m/news/2233376983?lang=&edition=full","pubTime":"2022-05-06 19:09","market":"us","language":"en","title":"Draftkings Shares Jumped 5% in Premarket Trading as Q1 Sales Beat Estimate\t","url":"https://stock-news.laohu8.com/highlight/detail?id=2233376983","media":"seekingalpha","summary":"DraftKings  (NASDAQ:DKNG): Q1 Revenue of $417M (+33.7% Y/Y)  beats by $5.76M. DraftKings shares jump","content":"<html><head></head><body><p>DraftKings  (NASDAQ:DKNG): Q1 Revenue of $417M (+33.7% Y/Y)  beats by $5.76M. DraftKings shares jumped 5% in premarket trading.</p><p><img src=\"https://static.tigerbbs.com/50de0a33a32dd9ce65c1d6958e05f43a\" tg-width=\"836\" tg-height=\"654\" referrerpolicy=\"no-referrer\"/></p><p>Monthly Unique Payers increased to 2M monthly unique paying customers, representing an increase of 29% Y/Y.</p><p>Average Revenue per MUP was $67, representing an 11% increase Y/Y.</p><p>The company is raising its FY2022 revenue guidance from a range of $1.85B to $2B to a range of $1.925B to $2.025B, which equates to Y/Y growth of 49% to 56% vs. consensus of $1.98B; Adjusted EBITDA guidance from between a loss of $825M and $925M to between a loss of $760M and $840M.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Draftkings Shares Jumped 5% in Premarket Trading as Q1 Sales Beat Estimate\t</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDraftkings Shares Jumped 5% in Premarket Trading as Q1 Sales Beat Estimate\t\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-06 19:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3834174-draftkings-reports-q1-results-raises-fy2022-outlook><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DraftKings  (NASDAQ:DKNG): Q1 Revenue of $417M (+33.7% Y/Y)  beats by $5.76M. DraftKings shares jumped 5% in premarket trading.Monthly Unique Payers increased to 2M monthly unique paying customers, ...</p>\n\n<a href=\"https://seekingalpha.com/news/3834174-draftkings-reports-q1-results-raises-fy2022-outlook\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4150":"赌场与赌博","BK4565":"NFT概念","DKNG":"DraftKings Inc."},"source_url":"https://seekingalpha.com/news/3834174-draftkings-reports-q1-results-raises-fy2022-outlook","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"2233376983","content_text":"DraftKings  (NASDAQ:DKNG): Q1 Revenue of $417M (+33.7% Y/Y)  beats by $5.76M. DraftKings shares jumped 5% in premarket trading.Monthly Unique Payers increased to 2M monthly unique paying customers, representing an increase of 29% Y/Y.Average Revenue per MUP was $67, representing an 11% increase Y/Y.The company is raising its FY2022 revenue guidance from a range of $1.85B to $2B to a range of $1.925B to $2.025B, which equates to Y/Y growth of 49% to 56% vs. consensus of $1.98B; Adjusted EBITDA guidance from between a loss of $825M and $925M to between a loss of $760M and $840M.","news_type":1},"isVote":1,"tweetType":1,"viewCount":120,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066960431,"gmtCreate":1651839900323,"gmtModify":1676534981331,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066960431","repostId":"2233330483","repostType":4,"repost":{"id":"2233330483","pubTimestamp":1651838945,"share":"https://www.laohu8.com/m/news/2233330483?lang=&edition=full","pubTime":"2022-05-06 20:09","market":"us","language":"en","title":"Is It Safer to Pull Your Money Out of the Stock Market or Keep Investing for Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2233330483","media":"Motley Fool","summary":"Time in the market is important.","content":"<html><head></head><body><p>It can be nerve-wracking to watch your portfolio consistently drop during bear market periods. After all, nobody likes losing money; that goes against the whole purpose of investing. However, pulling your money out of the stock market during down periods can often do more harm than good in the long term. Here&#39;s why you should keep investing during such periods.</p><p><img src=\"https://static.tigerbbs.com/83e655a5c0301001b3e34cfe642835c7\" tg-width=\"700\" tg-height=\"458\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"/></p><p>Image source: Getty Images.</p><h2>Use down periods to lower your cost basis</h2><p>Although nobody likes seeing their investments decline in price, it can actually be a good opportunity for long-term investors because it&#39;s a chance to lower your cost basis. Your cost basis essentially tells you the average price you paid per share for a particular company. If you bought 10 shares of a company at $100 each, your cost basis would be $100. If the stock&#39;s price dropped to $80 and you purchased 10 more shares, your new cost basis would be $90 ($1,800 spent / 20 shares owned).</p><p>Lowering your cost basis is valuable because it increases your profit whenever you eventually sell your shares. Imagine you own 20 shares with a $90 cost basis, and someone else also owns 20 shares of the same company but with a $100 cost basis. If that stock&#39;s price increases to $150 and you both sell, you would have profited $1,200, and they would have profited $1,000.</p><p>Although you both own the same number of shares, your profits are higher because you were able to lower your cost basis.</p><p>If you&#39;re investing in sound businesses, don&#39;t panic over short-term drops in price; consider it a blessing in disguise and put yourself in a better long-term position.</p><h2>Time in the market is important</h2><p>&#34;Time in the market is better than timing the market&#34; is an investing saying that has stood the test of time -- and it&#39;s <a href=\"https://laohu8.com/S/AONE.U\">one</a> investors should always keep in mind. On one end, it points to how timing the market is virtually impossible to do consistently long term. It also speaks to the power of time in the market -- especially regarding dividends.</p><p>Companies pay out dividends to reward their shareholders for holding on to their investments. If you&#39;re investing in dividend-paying companies (preferably Dividend Aristocrats or Dividend Kings, which also have stood the test of time), you&#39;re doing yourself a disservice if you pull your money out due to drops in the market.</p><p>If you have $10,000 invested in a company or fund with a 3% annual dividend yield, you can expect to receive $300 in dividends each year. If the stock&#39;s price is rising, you can expect that dividend payout; if the stock&#39;s price is dropping, you can expect that dividend payout. The company&#39;s stock price shouldn&#39;t be your only focus as long as it manages to keep paying out dividends.</p><p>If you panic sell because the stock is dropping, you essentially remove an income source that could prove to be key to your return on investment. If the stock price drops and the value of your investment loses $200 in a year, but you made $300 from dividends, you still came out positive.</p><h2>Don&#39;t be an emotional investor</h2><p>As an investor, it&#39;s easy to get too high on the highs and too low on the lows in the short term. One of the best ways to remove some emotions from investing is applying dollar-cost averaging. Dollar-cost averaging involves making consistent investments at regular intervals, no matter what the stock price is at the time. It&#39;s how 401(k) plans operate; no matter the cost of the investments, you contribute your designated amount each pay period.</p><p>Focusing on the end goal and ignoring the short-term volatility can make investing less stressful and can help prevent you from making emotional decisions that may go against your best long-term interest. Keep your eyes on the prize.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Safer to Pull Your Money Out of the Stock Market or Keep Investing for Now?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Safer to Pull Your Money Out of the Stock Market or Keep Investing for Now?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-06 20:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/06/is-it-safer-to-pull-your-money-out-of-the-stock-ma/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It can be nerve-wracking to watch your portfolio consistently drop during bear market periods. After all, nobody likes losing money; that goes against the whole purpose of investing. However, pulling ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/06/is-it-safer-to-pull-your-money-out-of-the-stock-ma/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.fool.com/investing/2022/05/06/is-it-safer-to-pull-your-money-out-of-the-stock-ma/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2233330483","content_text":"It can be nerve-wracking to watch your portfolio consistently drop during bear market periods. After all, nobody likes losing money; that goes against the whole purpose of investing. However, pulling your money out of the stock market during down periods can often do more harm than good in the long term. Here's why you should keep investing during such periods.Image source: Getty Images.Use down periods to lower your cost basisAlthough nobody likes seeing their investments decline in price, it can actually be a good opportunity for long-term investors because it's a chance to lower your cost basis. Your cost basis essentially tells you the average price you paid per share for a particular company. If you bought 10 shares of a company at $100 each, your cost basis would be $100. If the stock's price dropped to $80 and you purchased 10 more shares, your new cost basis would be $90 ($1,800 spent / 20 shares owned).Lowering your cost basis is valuable because it increases your profit whenever you eventually sell your shares. Imagine you own 20 shares with a $90 cost basis, and someone else also owns 20 shares of the same company but with a $100 cost basis. If that stock's price increases to $150 and you both sell, you would have profited $1,200, and they would have profited $1,000.Although you both own the same number of shares, your profits are higher because you were able to lower your cost basis.If you're investing in sound businesses, don't panic over short-term drops in price; consider it a blessing in disguise and put yourself in a better long-term position.Time in the market is important\"Time in the market is better than timing the market\" is an investing saying that has stood the test of time -- and it's one investors should always keep in mind. On one end, it points to how timing the market is virtually impossible to do consistently long term. It also speaks to the power of time in the market -- especially regarding dividends.Companies pay out dividends to reward their shareholders for holding on to their investments. If you're investing in dividend-paying companies (preferably Dividend Aristocrats or Dividend Kings, which also have stood the test of time), you're doing yourself a disservice if you pull your money out due to drops in the market.If you have $10,000 invested in a company or fund with a 3% annual dividend yield, you can expect to receive $300 in dividends each year. If the stock's price is rising, you can expect that dividend payout; if the stock's price is dropping, you can expect that dividend payout. The company's stock price shouldn't be your only focus as long as it manages to keep paying out dividends.If you panic sell because the stock is dropping, you essentially remove an income source that could prove to be key to your return on investment. If the stock price drops and the value of your investment loses $200 in a year, but you made $300 from dividends, you still came out positive.Don't be an emotional investorAs an investor, it's easy to get too high on the highs and too low on the lows in the short term. One of the best ways to remove some emotions from investing is applying dollar-cost averaging. Dollar-cost averaging involves making consistent investments at regular intervals, no matter what the stock price is at the time. It's how 401(k) plans operate; no matter the cost of the investments, you contribute your designated amount each pay period.Focusing on the end goal and ignoring the short-term volatility can make investing less stressful and can help prevent you from making emotional decisions that may go against your best long-term interest. Keep your eyes on the prize.","news_type":1},"isVote":1,"tweetType":1,"viewCount":176,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066960693,"gmtCreate":1651839883713,"gmtModify":1676534981322,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066960693","repostId":"2233846183","repostType":4,"repost":{"id":"2233846183","pubTimestamp":1651850745,"share":"https://www.laohu8.com/m/news/2233846183?lang=&edition=full","pubTime":"2022-05-06 23:25","market":"us","language":"en","title":"Down 42%, This Dow Stock Is a Screaming Buy in May","url":"https://stock-news.laohu8.com/highlight/detail?id=2233846183","media":"Motley Fool","summary":"The stock's slump has created an opportunity for long-term investors to scoop up this iconic brand at a discount.","content":"<html><head></head><body><p><b>The Walt Disney Company</b>&#39;s stock has been on a roller-coaster ride, crashing at the pandemic&#39;s onset, recovering throughout 2020, then crashing again in early 2021. Overall, the stock is down 42% from its high in January 2021.</p><p>Investors are concerned about the business as consumer behavior evolves rapidly and unevenly worldwide. Regardless of the near-term challenges of navigating a global company during a pandemic, Disney&#39;s long-term prospects are excellent.</p><h2>The streaming segment is gaining traction</h2><p>The core of Disney&#39;s business is a treasure trove of proprietary characters and stories that have delighted consumers for decades. The difficult-to-replicate intellectual property flows into Disney&#39;s theme parks, movies, series, merchandise, cruise ships, hotels, and more. The crucial element of its business is based on proprietary content. That means competitors cannot infringe on its business without spending decades and billions of dollars to build a suite of characters and stories that spark consumers&#39; enthusiasm.</p><p><img src=\"https://static.tigerbbs.com/0fa69891eadeb8756e472c900570e2c4\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"/></p><p>DIS Revenue (Quarterly) data by YCharts</p><p>But the past decade has been tricky. Disney has had to navigate the transitioning of its legacy cable TV business over to streaming. The legacy method was a boon for The House of Mouse, so it was careful not to switch to streaming hastily. Nevertheless, in 2019 it committed to streaming entirely and launched its flagship service Disney+. As of Jan. 1, the service boasts 130 million subscribers, and the streaming segment as a whole (which also includes Hulu and ESPN+) has attracted 196.4 million.</p><p>Management forecasts that Disney+ will reach between 230 million and 260 million subs by 2024 and be profitable. To put that potential into context, <b>Netflix</b> surpassed 200 million subs in 2021 and reported revenue of $29.7 billion that year. In 2019, before the coronavirus disrupted operations, Disney&#39;s revenue was $69.6 billion. Home to iconic franchises like Pixar, Star Wars, Marvel, and Mickey Mouse, Disney can reasonably reach and surpass Netflix&#39;s achievements.</p><h2>The theme parks are emerging stronger than before</h2><p>In 2019, Disney&#39;s theme parks generated $24.7 billion in revenue and $6.1 billion in operating income. Of course, the pandemic devastated the business, but it is bouncing back and more vital than ever. In its recently completed quarter, which ended in January, Disney&#39;s theme park segment produced $7.2 billion in revenue and $2.5 billion in operating income. Despite self-imposed capacity restrictions, the segment is on pace to eclipse 2019 totals.</p><p><img src=\"https://static.tigerbbs.com/28f7b70083e47a542aab5b7dbb2bb434\" tg-width=\"720\" tg-height=\"433\" referrerpolicy=\"no-referrer\"/></p><p>DIS Operating Income (Annual) data by YCharts</p><p>When the parks were forced to shut down to guests, management developed and implemented several improvements. These included a digital reservation system that allows the company to manage attendance effectively, mobile ordering at food and concession stands, and premium features like Genie+, which enables guests to pay for the privilege of skipping lines.</p><p>This likely means that the parks will be more profitable from now on than before the pandemic&#39;s onset. The near term might be volatile as consumer behavior changes with COVID-19 trends. However, Disney&#39;s unique and valuable assets are likely to attract consumers in large numbers over the longer run. And the stock&#39;s 44% crash from its high only makes this investment a better value.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Down 42%, This Dow Stock Is a Screaming Buy in May</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDown 42%, This Dow Stock Is a Screaming Buy in May\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-06 23:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/05/this-dow-stock-screaming-buy-in-may-disney/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Walt Disney Company's stock has been on a roller-coaster ride, crashing at the pandemic's onset, recovering throughout 2020, then crashing again in early 2021. Overall, the stock is down 42% from ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/05/this-dow-stock-screaming-buy-in-may-disney/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼","BK4507":"流媒体概念","BK4581":"高盛持仓","BK4550":"红杉资本持仓","QNETCN":"纳斯达克中美互联网老虎指数","BK4527":"明星科技股","BK4566":"资本集团","BK4532":"文艺复兴科技持仓","BK4534":"瑞士信贷持仓","BK4554":"元宇宙及AR概念","BK4108":"电影和娱乐","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4524":"宅经济概念","NFLX":"奈飞","BK4561":"索罗斯持仓"},"source_url":"https://www.fool.com/investing/2022/05/05/this-dow-stock-screaming-buy-in-may-disney/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2233846183","content_text":"The Walt Disney Company's stock has been on a roller-coaster ride, crashing at the pandemic's onset, recovering throughout 2020, then crashing again in early 2021. Overall, the stock is down 42% from its high in January 2021.Investors are concerned about the business as consumer behavior evolves rapidly and unevenly worldwide. Regardless of the near-term challenges of navigating a global company during a pandemic, Disney's long-term prospects are excellent.The streaming segment is gaining tractionThe core of Disney's business is a treasure trove of proprietary characters and stories that have delighted consumers for decades. The difficult-to-replicate intellectual property flows into Disney's theme parks, movies, series, merchandise, cruise ships, hotels, and more. The crucial element of its business is based on proprietary content. That means competitors cannot infringe on its business without spending decades and billions of dollars to build a suite of characters and stories that spark consumers' enthusiasm.DIS Revenue (Quarterly) data by YChartsBut the past decade has been tricky. Disney has had to navigate the transitioning of its legacy cable TV business over to streaming. The legacy method was a boon for The House of Mouse, so it was careful not to switch to streaming hastily. Nevertheless, in 2019 it committed to streaming entirely and launched its flagship service Disney+. As of Jan. 1, the service boasts 130 million subscribers, and the streaming segment as a whole (which also includes Hulu and ESPN+) has attracted 196.4 million.Management forecasts that Disney+ will reach between 230 million and 260 million subs by 2024 and be profitable. To put that potential into context, Netflix surpassed 200 million subs in 2021 and reported revenue of $29.7 billion that year. In 2019, before the coronavirus disrupted operations, Disney's revenue was $69.6 billion. Home to iconic franchises like Pixar, Star Wars, Marvel, and Mickey Mouse, Disney can reasonably reach and surpass Netflix's achievements.The theme parks are emerging stronger than beforeIn 2019, Disney's theme parks generated $24.7 billion in revenue and $6.1 billion in operating income. Of course, the pandemic devastated the business, but it is bouncing back and more vital than ever. In its recently completed quarter, which ended in January, Disney's theme park segment produced $7.2 billion in revenue and $2.5 billion in operating income. Despite self-imposed capacity restrictions, the segment is on pace to eclipse 2019 totals.DIS Operating Income (Annual) data by YChartsWhen the parks were forced to shut down to guests, management developed and implemented several improvements. These included a digital reservation system that allows the company to manage attendance effectively, mobile ordering at food and concession stands, and premium features like Genie+, which enables guests to pay for the privilege of skipping lines.This likely means that the parks will be more profitable from now on than before the pandemic's onset. The near term might be volatile as consumer behavior changes with COVID-19 trends. However, Disney's unique and valuable assets are likely to attract consumers in large numbers over the longer run. And the stock's 44% crash from its high only makes this investment a better value.","news_type":1},"isVote":1,"tweetType":1,"viewCount":166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066960803,"gmtCreate":1651839868102,"gmtModify":1676534981322,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Sharing&nbsp;","listText":"Sharing&nbsp;","text":"Sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066960803","repostId":"2233330483","repostType":4,"isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9066960008,"gmtCreate":1651839830304,"gmtModify":1676534981313,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>sharing","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>sharing","text":"$Novavax(NVAX)$sharing","images":[{"img":"https://community-static.tradeup.com/news/8fc14409a91d886fbc13b5c511c69343","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066960008","isVote":1,"tweetType":1,"viewCount":89,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9066987413,"gmtCreate":1651839791732,"gmtModify":1676534981303,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/QQQ\">$Invesco QQQ Trust(QQQ)$</a>sharing","listText":"<a href=\"https://ttm.financial/S/QQQ\">$Invesco QQQ Trust(QQQ)$</a>sharing","text":"$Invesco QQQ Trust(QQQ)$sharing","images":[{"img":"https://community-static.tradeup.com/news/520b9903ef252051dbae265ac4d0228b","width":"1080","height":"2530"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9066987413","isVote":1,"tweetType":1,"viewCount":40,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9068656747,"gmtCreate":1651764835890,"gmtModify":1676534965395,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://community-static.tradeup.com/news/97c7718a9d9ee3866431fb3096f06c0a","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9068656747","isVote":1,"tweetType":1,"viewCount":23,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9068656936,"gmtCreate":1651764807025,"gmtModify":1676534965372,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/GDX\">$VanEck Gold Miners ETF(GDX)$</a>sharing","listText":"<a href=\"https://ttm.financial/S/GDX\">$VanEck Gold Miners ETF(GDX)$</a>sharing","text":"$VanEck Gold Miners ETF(GDX)$sharing","images":[{"img":"https://community-static.tradeup.com/news/5a71830d1035ff7ea1b6c08dcd64ad97","width":"1080","height":"2431"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9068656936","isVote":1,"tweetType":1,"viewCount":4,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9061756775,"gmtCreate":1651683230467,"gmtModify":1676534948869,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/TMO\">$Thermo Fisher Scientific(TMO)$</a>sharing","listText":"<a href=\"https://ttm.financial/S/TMO\">$Thermo Fisher Scientific(TMO)$</a>sharing","text":"$Thermo Fisher Scientific(TMO)$sharing","images":[{"img":"https://community-static.tradeup.com/news/955bfba7871409a26c55fe2e9467e181","width":"1080","height":"2431"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061756775","isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9061756287,"gmtCreate":1651683107753,"gmtModify":1676534948774,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://community-static.tradeup.com/news/1ada5ec4c0e2d8a04931dc74c6f54775","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061756287","isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://community-static.tradeup.com/news/58fdf90023b13bdabb45b46bb0d645e1","crmLevel":3,"crmLevelSwitch":1},"content":"I know, a long road back. hopefully journey started in ernest.","text":"I know, a long road back. hopefully journey started in ernest.","html":"I know, a long road back. hopefully journey started in ernest."}],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":895583219,"gmtCreate":1628756684831,"gmtModify":1676529844042,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Please like. Thanks&nbsp;","listText":"Please like. Thanks&nbsp;","text":"Please like. Thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/895583219","repostId":"1162340118","repostType":4,"repost":{"id":"1162340118","pubTimestamp":1628754148,"share":"https://www.laohu8.com/m/news/1162340118?lang=&edition=full","pubTime":"2021-08-12 15:42","market":"us","language":"en","title":"IPhone Maker Predicts Slowing Gadget Sales Just as Holidays Loom","url":"https://stock-news.laohu8.com/highlight/detail?id=1162340118","media":"Bloomberg","summary":"Apple’s main assembly partner Hon Hai Precision Industry Co. projected sales of gadgets like smartph","content":"<p><a href=\"https://laohu8.com/S/AAPL\">Apple</a>’s main assembly partner&nbsp;Hon Hai Precision Industry Co.&nbsp;projected sales of gadgets like smartphones will drop sequentially this quarter, spurring concerns that chip and component shortages may affect iPhone production before the holiday season.</p>\n<p>Sales at the manufacturer’s consumer electronics business, which includes the iPhone, will decline this quarter compared with the previous three months, the company said Thursday. The downbeat projection caught analysts by surprise, given the third quarter is often the peak production season for a global electronics industry thatscrambles every year to get devices in front of shoppers before the year ends.</p>\n<p>The forecast raises questions about whether brands such as Apple, which is&nbsp;preparing&nbsp;to bring out the latest iPhone, will be able to meet demand fueled by the pandemic. A persistent shortage of chips and other parts is weighing on the output of iPhones, gaming consoles and servers, while consumers continue to snatch up devices for remote work, home-schooling and entertainment needs.</p>\n<p>Apple warned analysts about a component shortage in April and&nbsp;said&nbsp;in late July that supply constraints will affect the iPhone and iPad in the current quarter. Hon Hai Chairman Young Liusaidin May that component shortages will affect shipments by 10% this year. In recent weeks, several chipmakers and car firmshave saidthe chip crunch is far from over.</p>\n<p>On Thursday, Liu said high comparison numbers in the previous quarter as well as product transitioning will result in the slight sequential sales decline in the consumer electronics unit. Total revenue will be little changed sequentially, Hon Hai said. Component shortages will last into the second quarter of next year, and the issue is having a limited impact on Hon Hai, Liu said.</p>\n<p>Hon Hai’s second-quarter net income rose to NT$29.8 billion ($1.07 billion), beating the NT$25.7 billion average of analysts’&nbsp;estimates. Sales in the three months ended June rose 20% to NT$1.35 trillion, according to numbers reported previously.</p>\n<p>To ensure sufficient supplies going forward, Hon Hai, the world’s largest contract electronics manufacturer and main assembler of iPhones, has struck various semiconductor pacts. It agreed to&nbsp;acquire&nbsp;a mature 6-inch wafer plant from Macronix International Co., and is&nbsp;setting upa chip joint venture with Yageo Corp.</p>\n<p>The company, the flagship unit of Foxconn Technology Group, is also targeting electric vehicles to diversify its business beyond making gadgets for Apple, which accounts for about 50% of its revenue.</p>\n<p>The company will build electric-vehicle plants in various regions, including the U.S., where it is still looking for a production site, Liu said. It plans to start mass production of EVs in Thailand and the U.S. in 2023, he said. The company may consider setting up an EV plant in Europe, Liu said.</p>\n<p>Foxconn has created an open EV platform,&nbsp;inked&nbsp;a manufacturing deal with U.S.-based Fisker Inc. and reached an agreement to&nbsp;partner with&nbsp;Stellantis NV on a joint venture to develop digital car cockpits. It has also&nbsp;struck&nbsp;a multibillion-dollar EV partnership with Thailand’s state-owned conglomerate&nbsp;PTT Pcl.</p>\n<p>Foxconn is among a coterie of suppliers and assemblers set to vie for a role in the production of a potential Apple car.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>IPhone Maker Predicts Slowing Gadget Sales Just as Holidays Loom</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIPhone Maker Predicts Slowing Gadget Sales Just as Holidays Loom\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-12 15:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-12/iphone-maker-hon-hai-s-profit-beats-as-covid-fuels-gadget-demand?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple’s main assembly partner Hon Hai Precision Industry Co. projected sales of gadgets like smartphones will drop sequentially this quarter, spurring concerns that chip and component shortages may ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-12/iphone-maker-hon-hai-s-profit-beats-as-covid-fuels-gadget-demand?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果","HNHPF":"Hon Hai Precision Industry Co. Ltd.","HNHAF":"Hon Hai Precision Industry Co. Ltd."},"source_url":"https://www.bloomberg.com/news/articles/2021-08-12/iphone-maker-hon-hai-s-profit-beats-as-covid-fuels-gadget-demand?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162340118","content_text":"Apple’s main assembly partner Hon Hai Precision Industry Co. projected sales of gadgets like smartphones will drop sequentially this quarter, spurring concerns that chip and component shortages may affect iPhone production before the holiday season.\nSales at the manufacturer’s consumer electronics business, which includes the iPhone, will decline this quarter compared with the previous three months, the company said Thursday. The downbeat projection caught analysts by surprise, given the third quarter is often the peak production season for a global electronics industry thatscrambles every year to get devices in front of shoppers before the year ends.\nThe forecast raises questions about whether brands such as Apple, which is preparing to bring out the latest iPhone, will be able to meet demand fueled by the pandemic. A persistent shortage of chips and other parts is weighing on the output of iPhones, gaming consoles and servers, while consumers continue to snatch up devices for remote work, home-schooling and entertainment needs.\nApple warned analysts about a component shortage in April and said in late July that supply constraints will affect the iPhone and iPad in the current quarter. Hon Hai Chairman Young Liusaidin May that component shortages will affect shipments by 10% this year. In recent weeks, several chipmakers and car firmshave saidthe chip crunch is far from over.\nOn Thursday, Liu said high comparison numbers in the previous quarter as well as product transitioning will result in the slight sequential sales decline in the consumer electronics unit. Total revenue will be little changed sequentially, Hon Hai said. Component shortages will last into the second quarter of next year, and the issue is having a limited impact on Hon Hai, Liu said.\nHon Hai’s second-quarter net income rose to NT$29.8 billion ($1.07 billion), beating the NT$25.7 billion average of analysts’ estimates. Sales in the three months ended June rose 20% to NT$1.35 trillion, according to numbers reported previously.\nTo ensure sufficient supplies going forward, Hon Hai, the world’s largest contract electronics manufacturer and main assembler of iPhones, has struck various semiconductor pacts. It agreed to acquire a mature 6-inch wafer plant from Macronix International Co., and is setting upa chip joint venture with Yageo Corp.\nThe company, the flagship unit of Foxconn Technology Group, is also targeting electric vehicles to diversify its business beyond making gadgets for Apple, which accounts for about 50% of its revenue.\nThe company will build electric-vehicle plants in various regions, including the U.S., where it is still looking for a production site, Liu said. It plans to start mass production of EVs in Thailand and the U.S. in 2023, he said. The company may consider setting up an EV plant in Europe, Liu said.\nFoxconn has created an open EV platform, inked a manufacturing deal with U.S.-based Fisker Inc. and reached an agreement to partner with Stellantis NV on a joint venture to develop digital car cockpits. It has also struck a multibillion-dollar EV partnership with Thailand’s state-owned conglomerate PTT Pcl.\nFoxconn is among a coterie of suppliers and assemblers set to vie for a role in the production of a potential Apple car.","news_type":1},"isVote":1,"tweetType":1,"viewCount":41,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":804733747,"gmtCreate":1627978917889,"gmtModify":1703498991370,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like like","listText":"Like like","text":"Like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":4,"repostSize":0,"link":"https://ttm.financial/post/804733747","repostId":"2156462011","repostType":4,"repost":{"id":"2156462011","pubTimestamp":1627978238,"share":"https://www.laohu8.com/m/news/2156462011?lang=&edition=full","pubTime":"2021-08-03 16:10","market":"us","language":"en","title":"Sanofi to Buy Translate Bio for $3.2 Billion in mRNA Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2156462011","media":"Bloomberg","summary":"(Bloomberg) -- Sanofi agreed to acquire its messenger-RNA development partner Translate Bio Inc. for","content":"<p>(Bloomberg) -- <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a> agreed to acquire its messenger-RNA development partner <a href=\"https://laohu8.com/S/TBIO\">Translate Bio Inc.</a> for $3.2 billion, scooping up a biotech company steeped in the technology behind some of the world’s top-selling Covid-19 vaccines.</p>\n<p>The French drugmaker will pay $38 in cash for each of Translate Bio’s shares, a 30% premium to Monday’s closing price. The boards of directors of both companies approved the transaction, according to a statement Tuesday.</p>\n<p>Ordinarily a giant in the vaccines space, Sanofi is playing catch-up with Covid after upstarts <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> and Moderna Inc. raced ahead with highly effective mRNA shots that have now been injected into arms more than a billion times. Those two companies have been lavishly rewarded for their pioneering work, with Moderna’s market valuation rocketing toward $140 billion as of Monday and BioNTech’s valuation now exceeding $80 billion.</p>\n<p>Pfizer Inc., which is partnered with Germany’s BioNTech, said last week that their Covid shot could bring in $33.5 billion in revenue this year alone.</p>\n<p>“Our goal is to unlock the potential of mRNA in other strategic areas such as immunology, oncology and rare diseases in addition to vaccines,” Sanofi Chief Executive Officer Paul Hudson said in the statement.</p>\n<p>Sanofi hasn’t brought a Covid vaccine to market yet. Its leading candidate is based on the recombinant-protein technology already in use in the company’s seasonal flu shots. That product, which was subject to months of delays, is now in a late-stage trial and could be cleared by regulators by the end of this year.</p>\n<p>But Sanofi has also been developing an mRNA Covid shot with Translate Bio since March 2020. That effort grew out of a partnership between the companies, forged in 2018, to develop mRNA vaccines for as many as five infectious-disease pathogens. Their Covid candidate is currently in an early-stage trial, with results expected by the end of September, and it could be approved, if all goes well, in 2022.</p>\n<p><b>Product Pipeline</b></p>\n<p>Translate Bio, based in Lexington, Massachusetts, also has an early-stage vaccine for influenza with Sanofi, with results expected later this year. Its pipeline of other products includes experimental therapies for cystic fibrosis and other lung ailments, along with treatments for diseases that affect the liver.</p>\n<p>Translate Bio CEO Ronald Renaud and its largest shareholder, The Baupost Group LLC, have both signed binding commitments to support the tender offer, with their stakes and shares already held by Sanofi representing about 30% of total outstanding stock, the statement said. Sanofi expects to close the deal later this quarter.</p>\n<p>In June, Sanofi announced plans to invest about $480 million a year in mRNA technology with a newly created “center of excellence” focused on everything from basic research to manufacturing. That initiative is aimed at speeding up the pipeline of mRNA products being developed by Sanofi and Translate Bio, along with making mRNA shots that are more stable at average temperatures and less likely to cause side effects.</p>\n<p>Sanofi expects at least six mRNA vaccine candidates in clinical trials by 2025.</p>\n<p>Translate Bio surged over 29%&nbsp;in premarket trading,&nbsp;Sanofi was up 0.08% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/8514618a621d11049dd9b715b8471eb9\" tg-width=\"946\" tg-height=\"633\" referrerpolicy=\"no-referrer\"><img src=\"https://static.tigerbbs.com/64fb14c92d3c3139477018d687b800a2\" tg-width=\"946\" tg-height=\"633\" referrerpolicy=\"no-referrer\"></p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi to Buy Translate Bio for $3.2 Billion in mRNA Push</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi to Buy Translate Bio for $3.2 Billion in mRNA Push\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-03 16:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-08-02/sanofi-offers-to-buy-translate-bio-in-mrna-push-reuters-reports?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Sanofi agreed to acquire its messenger-RNA development partner Translate Bio Inc. for $3.2 billion, scooping up a biotech company steeped in the technology behind some of the world’s ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-08-02/sanofi-offers-to-buy-translate-bio-in-mrna-push-reuters-reports?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","relate_stocks":{"TBIO":"TELESIS BIO","SNYNF":"Sanofi","BNTX":"BioNTech SE","SNY":"赛诺菲安万特","MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-08-02/sanofi-offers-to-buy-translate-bio-in-mrna-push-reuters-reports?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2156462011","content_text":"(Bloomberg) -- Sanofi agreed to acquire its messenger-RNA development partner Translate Bio Inc. for $3.2 billion, scooping up a biotech company steeped in the technology behind some of the world’s top-selling Covid-19 vaccines.\nThe French drugmaker will pay $38 in cash for each of Translate Bio’s shares, a 30% premium to Monday’s closing price. The boards of directors of both companies approved the transaction, according to a statement Tuesday.\nOrdinarily a giant in the vaccines space, Sanofi is playing catch-up with Covid after upstarts BioNTech SE and Moderna Inc. raced ahead with highly effective mRNA shots that have now been injected into arms more than a billion times. Those two companies have been lavishly rewarded for their pioneering work, with Moderna’s market valuation rocketing toward $140 billion as of Monday and BioNTech’s valuation now exceeding $80 billion.\nPfizer Inc., which is partnered with Germany’s BioNTech, said last week that their Covid shot could bring in $33.5 billion in revenue this year alone.\n“Our goal is to unlock the potential of mRNA in other strategic areas such as immunology, oncology and rare diseases in addition to vaccines,” Sanofi Chief Executive Officer Paul Hudson said in the statement.\nSanofi hasn’t brought a Covid vaccine to market yet. Its leading candidate is based on the recombinant-protein technology already in use in the company’s seasonal flu shots. That product, which was subject to months of delays, is now in a late-stage trial and could be cleared by regulators by the end of this year.\nBut Sanofi has also been developing an mRNA Covid shot with Translate Bio since March 2020. That effort grew out of a partnership between the companies, forged in 2018, to develop mRNA vaccines for as many as five infectious-disease pathogens. Their Covid candidate is currently in an early-stage trial, with results expected by the end of September, and it could be approved, if all goes well, in 2022.\nProduct Pipeline\nTranslate Bio, based in Lexington, Massachusetts, also has an early-stage vaccine for influenza with Sanofi, with results expected later this year. Its pipeline of other products includes experimental therapies for cystic fibrosis and other lung ailments, along with treatments for diseases that affect the liver.\nTranslate Bio CEO Ronald Renaud and its largest shareholder, The Baupost Group LLC, have both signed binding commitments to support the tender offer, with their stakes and shares already held by Sanofi representing about 30% of total outstanding stock, the statement said. Sanofi expects to close the deal later this quarter.\nIn June, Sanofi announced plans to invest about $480 million a year in mRNA technology with a newly created “center of excellence” focused on everything from basic research to manufacturing. That initiative is aimed at speeding up the pipeline of mRNA products being developed by Sanofi and Translate Bio, along with making mRNA shots that are more stable at average temperatures and less likely to cause side effects.\nSanofi expects at least six mRNA vaccine candidates in clinical trials by 2025.\nTranslate Bio surged over 29% in premarket trading, Sanofi was up 0.08% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9030823328,"gmtCreate":1645687122517,"gmtModify":1676534053692,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://static.itradeup.com/news/4b20191c2ddf5715ace3494bd6e623c1","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9030823328","isVote":1,"tweetType":1,"viewCount":350,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3575537003016625","authorId":"3575537003016625","name":"Broccolini","avatar":"https://static.tigerbbs.com/54c299a6e74bf12c242820d48cce2d41","crmLevel":7,"crmLevelSwitch":1},"content":"I have cut loss at -65%. What a disappointment.","text":"I have cut loss at -65%. What a disappointment.","html":"I have cut loss at -65%. What a disappointment."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":813122223,"gmtCreate":1630155795662,"gmtModify":1676530235824,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Liking king like&nbsp;","listText":"Liking king like&nbsp;","text":"Liking king like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/813122223","repostId":"2162733980","repostType":4,"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9081988840,"gmtCreate":1650180392100,"gmtModify":1676534664798,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://community-static.tradeup.com/news/680e46b58304306f1d442eed79ba7d24","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9081988840","isVote":1,"tweetType":1,"viewCount":297,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9093719362,"gmtCreate":1643705226709,"gmtModify":1676533846612,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://static.itradeup.com/news/fa79425cea323ea074e8709195276519","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9093719362","isVote":1,"tweetType":1,"viewCount":752,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4095899458661630","authorId":"4095899458661630","name":"Trax","avatar":"https://static.tigerbbs.com/1645bafcbb2131af6ed7383b7ccfb64d","crmLevel":3,"crmLevelSwitch":0},"content":"hopefully up back soon","text":"hopefully up back soon","html":"hopefully up back soon"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":886823187,"gmtCreate":1631581039249,"gmtModify":1676530580336,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Wah lao eh","listText":"Wah lao eh","text":"Wah lao eh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/886823187","repostId":"1178276551","repostType":4,"repost":{"id":"1178276551","pubTimestamp":1631574947,"share":"https://www.laohu8.com/m/news/1178276551?lang=&edition=full","pubTime":"2021-09-14 07:15","market":"us","language":"en","title":"S&P 500 snaps losing streak with tax hikes, inflation data on horizon","url":"https://stock-news.laohu8.com/highlight/detail?id=1178276551","media":"Reuters","summary":"NEW YORK (Reuters) - The S&P 500 closed higher on Monday, ending a five-day losing streak as investo","content":"<p>NEW YORK (Reuters) - The S&amp;P 500 closed higher on Monday, ending a five-day losing streak as investors focused on potential corporate tax hikes and upcoming economic data.</p>\n<p>The Dow Jones Industrial Average also advanced, but the Nasdaq Composite Index ended lower.</p>\n<p>Investors favored value over growth, with stocks set to benefit most from a resurging economy enjoying the biggest percentage gains.</p>\n<p>“There are probably not a lot of positive surprises coming this month,” said Liz Young, head of investment strategy at SoFi in New York. “We’re having another period of volatility where I think that rotation could go back to cyclicals and the reopened trade, as the 10-year bond rate slowly grinds higher through the end of the year.”</p>\n<p>Market participants are focused on the likely passage of U.S. President Joe Biden’s $3.5 trillion budget package, which is expected to include a proposed corporate tax rate hike to 26.5% from 21%.</p>\n<p>Goldman Sachs analysts see the corporate tax rate increasing to 25% and the passage of about half of a proposed increase to tax rates on foreign income, which they estimate would reduce S&amp;P 500 earnings by 5% in 2022.</p>\n<p>The Labor Department is due to release its consumer price index data on Tuesday, which could shed further light on the current inflation wave and whether it is as transitory as the Fed insists.</p>\n<p>“I don’t see inflation settling back down under 2% where it was pre-pandemic,” Young added. “Even if some of those transitory forces weaken, we will still stay at a higher rate than we were before.”</p>\n<p>Other key indicators due this week include retail sales and consumer sentiment, which could illuminate how much the demand boom driven by economic re-engagement has been dampened by the highly contagious COVID-19 Delta variant.</p>\n<p>The Dow Jones Industrial Average rose 261.91 points, or 0.76%, to 34,869.63, the S&amp;P 500 gained 10.15 points, or 0.23%, at 4,468.73 and the Nasdaq Composite dropped 9.91 points, or 0.07%, to 15,105.58.</p>\n<p>Of the 11 major sectors in the S&amp;P 500, healthcare suffered the largest percentage loss, while energy, buoyed by rising crude prices was the biggest gainer.</p>\n<p>Shares of vaccine makers Moderna and Pfizer Inc sank 6.6% and 2.2%, respectively, after experts said COVID booster shots are not widely needed.</p>\n<p>Coinbase Global Inc announced plans to raise about $1.5 billion through a debt offering aimed at funding product development and potential acquisitions. The cryptocurrency exchanges shares slid 2.2%.</p>\n<p>Salesforce.com Inc dipped 1.2% as rival Freshworks Inc’s regulatory filing indicated that the business engagement and customer engagement software company is aiming for a nearly $9 billion valuation in it U.S. debut.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.60-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 12 new 52-week highs and one new low; the Nasdaq Composite recorded 53 new highs and 71 new lows.</p>\n<p>Volume on U.S. exchanges was 10.30 billion shares, compared with the 9.29 billion average over the last 20 trading days.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 snaps losing streak with tax hikes, inflation data on horizon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 snaps losing streak with tax hikes, inflation data on horizon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-14 07:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-snaps-losing-streak-with-tax-hikes-inflation-data-on-horizon-idUSL1N2QF2DB><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - The S&P 500 closed higher on Monday, ending a five-day losing streak as investors focused on potential corporate tax hikes and upcoming economic data.\nThe Dow Jones Industrial ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-snaps-losing-streak-with-tax-hikes-inflation-data-on-horizon-idUSL1N2QF2DB\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-snaps-losing-streak-with-tax-hikes-inflation-data-on-horizon-idUSL1N2QF2DB","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178276551","content_text":"NEW YORK (Reuters) - The S&P 500 closed higher on Monday, ending a five-day losing streak as investors focused on potential corporate tax hikes and upcoming economic data.\nThe Dow Jones Industrial Average also advanced, but the Nasdaq Composite Index ended lower.\nInvestors favored value over growth, with stocks set to benefit most from a resurging economy enjoying the biggest percentage gains.\n“There are probably not a lot of positive surprises coming this month,” said Liz Young, head of investment strategy at SoFi in New York. “We’re having another period of volatility where I think that rotation could go back to cyclicals and the reopened trade, as the 10-year bond rate slowly grinds higher through the end of the year.”\nMarket participants are focused on the likely passage of U.S. President Joe Biden’s $3.5 trillion budget package, which is expected to include a proposed corporate tax rate hike to 26.5% from 21%.\nGoldman Sachs analysts see the corporate tax rate increasing to 25% and the passage of about half of a proposed increase to tax rates on foreign income, which they estimate would reduce S&P 500 earnings by 5% in 2022.\nThe Labor Department is due to release its consumer price index data on Tuesday, which could shed further light on the current inflation wave and whether it is as transitory as the Fed insists.\n“I don’t see inflation settling back down under 2% where it was pre-pandemic,” Young added. “Even if some of those transitory forces weaken, we will still stay at a higher rate than we were before.”\nOther key indicators due this week include retail sales and consumer sentiment, which could illuminate how much the demand boom driven by economic re-engagement has been dampened by the highly contagious COVID-19 Delta variant.\nThe Dow Jones Industrial Average rose 261.91 points, or 0.76%, to 34,869.63, the S&P 500 gained 10.15 points, or 0.23%, at 4,468.73 and the Nasdaq Composite dropped 9.91 points, or 0.07%, to 15,105.58.\nOf the 11 major sectors in the S&P 500, healthcare suffered the largest percentage loss, while energy, buoyed by rising crude prices was the biggest gainer.\nShares of vaccine makers Moderna and Pfizer Inc sank 6.6% and 2.2%, respectively, after experts said COVID booster shots are not widely needed.\nCoinbase Global Inc announced plans to raise about $1.5 billion through a debt offering aimed at funding product development and potential acquisitions. The cryptocurrency exchanges shares slid 2.2%.\nSalesforce.com Inc dipped 1.2% as rival Freshworks Inc’s regulatory filing indicated that the business engagement and customer engagement software company is aiming for a nearly $9 billion valuation in it U.S. debut.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.60-to-1 ratio; on Nasdaq, a 1.02-to-1 ratio favored advancers.\nThe S&P 500 posted 12 new 52-week highs and one new low; the Nasdaq Composite recorded 53 new highs and 71 new lows.\nVolume on U.S. exchanges was 10.30 billion shares, compared with the 9.29 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":59,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":819341252,"gmtCreate":1630037990376,"gmtModify":1676530207609,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like like please&nbsp;","listText":"Like like please&nbsp;","text":"Like like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/819341252","repostId":"1196717589","repostType":4,"repost":{"id":"1196717589","pubTimestamp":1630034074,"share":"https://www.laohu8.com/m/news/1196717589?lang=&edition=full","pubTime":"2021-08-27 11:14","market":"us","language":"en","title":"Who Owns The Most AMC Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=1196717589","media":"Thestreet","summary":"Of all the things to consider before buying a stock, understanding who owns the company’s equity is ","content":"<p>Of all the things to consider before buying a stock, understanding who owns the company’s equity is rarely a top-of-mind factor. In the case of AMC, however, the story may be a little different.</p>\n<p>Today, Wall Street Memes looks at AMC stock’s ownership and explains why it could have an impact on how the company operates – and how the stock behaves.</p>\n<p><b>AMC largest holders</b></p>\n<p>According to data provided byYahoo Finance, AMC has a float of 513 million shares. Of the total, about 74% is owned by the public, 25% by institutions and 0.3% by insiders – directors, company's officers, and those with access to company information before it becomes public.</p>\n<p>Among institutions, Vanguard and Blackrock are the top holders, with 8% and 6% of the shares, respectively. Naturally, these firms turn their holdings into shares of ETF, which in turn can (and usually do) end up owned by more individual investors.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/03a5fac491fbf01869bb0f43310b2bc9\" tg-width=\"1200\" tg-height=\"966\" referrerpolicy=\"no-referrer\"><span>Figure 1: AMC stock ownership.ChartMill</span></p>\n<p>In May, AMC's previous largest shareholder, China's Dalian Wanda Group Co,sold30.4 million of its shares purchased in 2012 for roughly $430 million – funny enough, only days before AMC stock spiked from $14 to over $60 apiece. Currently, Wanda owns only 10,000 shares, representing a small $420,000 in market value.</p>\n<p>After the large Wanda sale, AMC's CEO Adam Aronrevealedthat no entity held an ownership stake above 10%.</p>\n<h3>Implications for the stock</h3>\n<p>A company whose ownership is widely distributed across the general public, as is the case of AMC, can benefit in a couple of ways. For instance, AMC can implement or change company policy without necessarily being aligned first with a handful of key shareholders.</p>\n<p>AMC’s ownership layout allowed for something curious to happen recently. CEO Adam Aron put to a vote theissuanceof 25 million new shares, which was then vetoed by a majority of AMC shareholders due to fears over a share price decline. Were AMC primarily owned by only a few, the polling would have likely not even taken place.</p>\n<p>In the end, the ownership structure allows AMC the flexibility to make its strategic decisions with certain independence – unless the management team chooses to consult with the broader base of individual investors more often.</p>\n<h3>In conclusion</h3>\n<p>AMC stock is owned, by and large, by retail investors – roughly speaking, the AMC ape community. Based on the latest shareholder count&nbsp;providedby AMC itself, the percentage of general public ownership is now greater than 80%, with each retail investor holding around 120 shares ($5,000) on average.</p>\n<p>Wall Street Memes believes that this is a good setup for AMC’s retail investors, as the fate of the company depends much less on the agenda of large institutions and a few insiders.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Who Owns The Most AMC Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWho Owns The Most AMC Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-27 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/memestocks/amc/who-owns-the-most-amc-stock><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Of all the things to consider before buying a stock, understanding who owns the company’s equity is rarely a top-of-mind factor. In the case of AMC, however, the story may be a little different.\nToday...</p>\n\n<a href=\"https://www.thestreet.com/memestocks/amc/who-owns-the-most-amc-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMC":"AMC院线"},"source_url":"https://www.thestreet.com/memestocks/amc/who-owns-the-most-amc-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1196717589","content_text":"Of all the things to consider before buying a stock, understanding who owns the company’s equity is rarely a top-of-mind factor. In the case of AMC, however, the story may be a little different.\nToday, Wall Street Memes looks at AMC stock’s ownership and explains why it could have an impact on how the company operates – and how the stock behaves.\nAMC largest holders\nAccording to data provided byYahoo Finance, AMC has a float of 513 million shares. Of the total, about 74% is owned by the public, 25% by institutions and 0.3% by insiders – directors, company's officers, and those with access to company information before it becomes public.\nAmong institutions, Vanguard and Blackrock are the top holders, with 8% and 6% of the shares, respectively. Naturally, these firms turn their holdings into shares of ETF, which in turn can (and usually do) end up owned by more individual investors.\nFigure 1: AMC stock ownership.ChartMill\nIn May, AMC's previous largest shareholder, China's Dalian Wanda Group Co,sold30.4 million of its shares purchased in 2012 for roughly $430 million – funny enough, only days before AMC stock spiked from $14 to over $60 apiece. Currently, Wanda owns only 10,000 shares, representing a small $420,000 in market value.\nAfter the large Wanda sale, AMC's CEO Adam Aronrevealedthat no entity held an ownership stake above 10%.\nImplications for the stock\nA company whose ownership is widely distributed across the general public, as is the case of AMC, can benefit in a couple of ways. For instance, AMC can implement or change company policy without necessarily being aligned first with a handful of key shareholders.\nAMC’s ownership layout allowed for something curious to happen recently. CEO Adam Aron put to a vote theissuanceof 25 million new shares, which was then vetoed by a majority of AMC shareholders due to fears over a share price decline. Were AMC primarily owned by only a few, the polling would have likely not even taken place.\nIn the end, the ownership structure allows AMC the flexibility to make its strategic decisions with certain independence – unless the management team chooses to consult with the broader base of individual investors more often.\nIn conclusion\nAMC stock is owned, by and large, by retail investors – roughly speaking, the AMC ape community. Based on the latest shareholder count providedby AMC itself, the percentage of general public ownership is now greater than 80%, with each retail investor holding around 120 shares ($5,000) on average.\nWall Street Memes believes that this is a good setup for AMC’s retail investors, as the fate of the company depends much less on the agenda of large institutions and a few insiders.","news_type":1},"isVote":1,"tweetType":1,"viewCount":11,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":810563628,"gmtCreate":1629986895264,"gmtModify":1676530193634,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Oh ou jialat","listText":"Oh ou jialat","text":"Oh ou jialat","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/810563628","repostId":"1100464351","repostType":4,"repost":{"id":"1100464351","pubTimestamp":1629986331,"share":"https://www.laohu8.com/m/news/1100464351?lang=&edition=full","pubTime":"2021-08-26 21:58","market":"us","language":"en","title":"Apple could pass chip costs into higher iPhone 13 prices","url":"https://stock-news.laohu8.com/highlight/detail?id=1100464351","media":"Seeking Alpha","summary":"$Apple$ could raise the prices for its upcoming iPhone 13 lineup as chip manufacturing partner $Taiwan Semiconductor Manufacturing$ moves to raise its costs amid the ongoing global semiconductor shortage.DigiTimes, a publication with a strong record with news from industry sources, reports that TSMC could raise Apple's prices by 3% to 5%, costs that Apple might pass on to consumers.TSMC is reportedly raising overall prices from 10% to 20% but is offering a discount to its largest client. Apple a","content":"<p><a href=\"https://laohu8.com/S/AAPL\">Apple</a> (NASDAQ:AAPL)could raise the prices for its upcoming iPhone 13 lineup as chip manufacturing partner <a href=\"https://laohu8.com/S/TSM\">Taiwan Semiconductor Manufacturing</a> (NYSE:TSM)moves to raise its costs amid the ongoing global semiconductor shortage.</p>\n<p><i>DigiTimes</i>, a publication with a strong record with news from industry sources,&nbsp;reports&nbsp;that TSMC could raise Apple's prices by 3% to 5%, costs that Apple might pass on to consumers.</p>\n<p>TSMC is reportedly raising overall prices from 10% to 20% but is offering a discount to its largest client. Apple accounts for over 20% of the foundry's total wafer revenue.</p>\n<p>The iPhone 12 lineup debuted last year with four core models, two base and two Pro edition handsets. The prices ranged from $799 for the standard iPhone 12 to $1,099 for the&nbsp;iPhone 12 Max with 128GB of storage.</p>\n<p>Apple will unveil its newest family of handsets as early as next month and the prices will be announced at the launch event. Reports have suggested the so-called iPhone 13 lineup will include four models with the same sizes as the iPhone 12 family, faster A15 Bionic processors and larger batteries. The two Pro models are expected to feature an&nbsp;improved ultrawide camera lens.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple could pass chip costs into higher iPhone 13 prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple could pass chip costs into higher iPhone 13 prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-26 21:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3734458-apple-could-pass-chip-costs-into-higher-iphone-13-prices><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple (NASDAQ:AAPL)could raise the prices for its upcoming iPhone 13 lineup as chip manufacturing partner Taiwan Semiconductor Manufacturing (NYSE:TSM)moves to raise its costs amid the ongoing global ...</p>\n\n<a href=\"https://seekingalpha.com/news/3734458-apple-could-pass-chip-costs-into-higher-iphone-13-prices\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电","AAPL":"苹果"},"source_url":"https://seekingalpha.com/news/3734458-apple-could-pass-chip-costs-into-higher-iphone-13-prices","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1100464351","content_text":"Apple (NASDAQ:AAPL)could raise the prices for its upcoming iPhone 13 lineup as chip manufacturing partner Taiwan Semiconductor Manufacturing (NYSE:TSM)moves to raise its costs amid the ongoing global semiconductor shortage.\nDigiTimes, a publication with a strong record with news from industry sources, reports that TSMC could raise Apple's prices by 3% to 5%, costs that Apple might pass on to consumers.\nTSMC is reportedly raising overall prices from 10% to 20% but is offering a discount to its largest client. Apple accounts for over 20% of the foundry's total wafer revenue.\nThe iPhone 12 lineup debuted last year with four core models, two base and two Pro edition handsets. The prices ranged from $799 for the standard iPhone 12 to $1,099 for the iPhone 12 Max with 128GB of storage.\nApple will unveil its newest family of handsets as early as next month and the prices will be announced at the launch event. Reports have suggested the so-called iPhone 13 lineup will include four models with the same sizes as the iPhone 12 family, faster A15 Bionic processors and larger batteries. The two Pro models are expected to feature an improved ultrawide camera lens.","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":834112102,"gmtCreate":1629779296706,"gmtModify":1676530128807,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Like like","listText":"Like like","text":"Like like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/834112102","repostId":"1104413070","repostType":4,"repost":{"id":"1104413070","pubTimestamp":1629776596,"share":"https://www.laohu8.com/m/news/1104413070?lang=&edition=full","pubTime":"2021-08-24 11:43","market":"us","language":"en","title":"Apple: The $150 Struggle Is Real","url":"https://stock-news.laohu8.com/highlight/detail?id=1104413070","media":"seekingalpha","summary":"Summary\n\nApple is struggling to push past a ceiling on the stock at $150.\n5G iPhone units sold in FY","content":"<p>Summary</p>\n<ul>\n <li>Apple is struggling to push past a ceiling on the stock at $150.</li>\n <li>5G iPhone units sold in FY21 so far make for a high hurdle in FY22.</li>\n <li>The stock trades at an insanely 27x FY22 EPS estimates with minimal growth rates going forward.</li>\n <li>Looking for a helping hand in the market? Members of Out Fox The Street get exclusive ideas and guidance to navigate any climate.</li>\n</ul>\n<p>The COVID-19 work-from-home economy of 2020 provided a massive boost to technology companies that won't repeat over the next year.<b>Apple</b>(AAPL) was one of the biggest beneficiaries of forced technology spending over the last year with workers and students needing more computing power at home. My&nbsp;investment thesis&nbsp;is Bearish with the stock pressing towards all-time highs at $150 while business growth is decelerating.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2833adb73160ceb3c63fe72432275f37\" tg-width=\"990\" tg-height=\"400\" referrerpolicy=\"no-referrer\"><span>Source:FinViz</span></p>\n<p><b>Recency Bias</b></p>\n<p>One of the biggest mistakes made in the stock market is recency bias. An investor will naturally overweight the recent results of a business in deriving the correct current valuation for an equity.</p>\n<p>The current stock price is a prime example for Apple. The tech. giant has a huge history of growing over time, but Apple has also had a couple of periods in the last decade where revenues declined.</p>\n<p>The recent accelerated growth and shift to recurring services shouldn't alter one's view that Apple is still product-focused and will constantly run into down cycles. Investors must consider these likely outcomes when valuing the stock, but the current valuation is based on a recency bias of elevated growth in the last year.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/c80ba648538a7ec2481f78d288a21089\" tg-width=\"635\" tg-height=\"449\" referrerpolicy=\"no-referrer\"><span>Data byYCharts</span></p>\n<p>Even after another sterling quarter, analyst estimates are still forecasting a period of up to 4 years where Apple doesn't generate revenue growth in excess of 6%. TheFQ3'21 resultswere blow away numbers with revenues topping $80 billion and beating estimates by over $8 billion.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f6e1270cfc2e38d684e537fbccbca74f\" tg-width=\"640\" tg-height=\"168\" referrerpolicy=\"no-referrer\"><span>Source: Seeking Alphaearnings estimates</span></p>\n<p>The problem is that Apple had a nearly perfect quarter. The company admitted that Services revenue won't repeat the 33% growth in the June quarter and these tough comps are problematic for growth in future periods. Investors should easily understand that any growth after reporting a year with 33% growth is impressive, but some post covid slowdowns shouldn't be surprising.</p>\n<p>Right now though, Apple is still priced for excessive growth. A lot of the stock price gains in the last few years are attributed all to expanding P/E multiples. One only has to go back to 2016 for when Apple only traded at 10x trailing earnings. The stock now trades at nearly 30x trailing earnings, or nearly 3x the multiple from just 5 years ago.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/81f37f5c091cf6d63d100cf23afd6d94\" tg-width=\"635\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Data byYCharts</span></p>\n<p>If Apple only traded at 15x trailing earnings, the stock would trade closer to $75, not $150. For this reason, the stock has struggled to break above $150 for a while now.</p>\n<p>While the market forecasts 3% revenue growth for FY22, Citi analyst Wamsi Mohanmade it clearreal risk exists for Apple to actually report revenue and gross profit dollars down YoY in the first 3 quarters of the fiscal year:</p>\n<blockquote>\n Apple could be faced with the dual headwinds of tougher comps and weaker demand in Hardware only modestly offset by any Services re-acceleration. Revenue growth for F4Q was guided lower than the 36% y/y growth in F3Q, but the upcoming Dec, March and now even June quarters could be down y/y in revs and gross profit dollars given several headwinds.\n</blockquote>\n<p><b>iPhone 5G Cycle</b></p>\n<p>History tells us that Apple regularly has these product cycles and covid lockdowns should accelerate the likelihood of a future quarter with trough numbers. In addition, the 5G iPhone cycle should advance these normal cycles with sales pushed from the normal quarter into the December quarter last year. Normal sales for the iPhone 13 in the September quarter will accelerate the tough comps in the December quarter and on into FY22.</p>\n<p>TheCounterpoint chart&nbsp;highlights how the iPhone 12/5G cycle has elevated sales to a level where Apple faces tough comps in FY22. Not only were FQ1'21 sales elevated, but the FQ2'21/FQ3'21 units sold were far in excess of the prior two years.<img src=\"https://static.tigerbbs.com/df98a198f9efe54054ca28995635b11c\" tg-width=\"640\" tg-height=\"322\" referrerpolicy=\"no-referrer\"></p>\n<p>No real explanation exists for higher sales other than covid demand pulled forward and the 5G cycle. Even normal market growth wouldn't lead to unit sales surging somewhere in the 50% range for the March and June quarters from prior-year levels.</p>\n<p>Investors really have to question whether Apple can sell over 60 million units again in the March quarter and another 50 million units in the June quarter. Even selling iPhones at higher ASPs might not be enough to offset some declines in units sold.</p>\n<p>The crazy part here is that historical norms support Apple reporting some tough comps in the next year and going on to substantial growth in the next decade. The company has Services revenues up to $17.5 billion in quarterly sales accounting for some 21% of sales for the first 9 months of FY21.</p>\n<p>Apple is poised to roll these recurring revenues into more consistent growth, but the growth rates will be as annual revenues top $400 billion. Without the recency bias of the last year, investors would understand this concept and appropriately value the stock at a more normal valuation of ~15x future earnings.</p>\n<p>If the tech giant earns $5.92 in even FY23, the stock would only trade at $89 using a 15x multiple. Remember, one would normally question whether Apple even deserves a 15x forward multiple when earnings are only forecast to grow at a 5% clip in FY23. A stock usually struggles to trade at forward P/E multiples of 2x the growth rate, not 3x the growth rate.</p>\n<p><b>Takeaway</b></p>\n<p>The key investor takeaway is that investors should clearly understand why Apple is struggling to push beyond $150. The stock is already insanely expensive for the normalized growth rates going forward and the real risk that the tech giant actually reports a few quarters where revenues decline.</p>\n<p>Investors should be selling Apple at $150, not looking to buy even more shares at a price where the annualized returns should be weak.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple: The $150 Struggle Is Real</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple: The $150 Struggle Is Real\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-24 11:43 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4451389-apple-the-150-struggle-is-real><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nApple is struggling to push past a ceiling on the stock at $150.\n5G iPhone units sold in FY21 so far make for a high hurdle in FY22.\nThe stock trades at an insanely 27x FY22 EPS estimates ...</p>\n\n<a href=\"https://seekingalpha.com/article/4451389-apple-the-150-struggle-is-real\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4451389-apple-the-150-struggle-is-real","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1104413070","content_text":"Summary\n\nApple is struggling to push past a ceiling on the stock at $150.\n5G iPhone units sold in FY21 so far make for a high hurdle in FY22.\nThe stock trades at an insanely 27x FY22 EPS estimates with minimal growth rates going forward.\nLooking for a helping hand in the market? Members of Out Fox The Street get exclusive ideas and guidance to navigate any climate.\n\nThe COVID-19 work-from-home economy of 2020 provided a massive boost to technology companies that won't repeat over the next year.Apple(AAPL) was one of the biggest beneficiaries of forced technology spending over the last year with workers and students needing more computing power at home. My investment thesis is Bearish with the stock pressing towards all-time highs at $150 while business growth is decelerating.\nSource:FinViz\nRecency Bias\nOne of the biggest mistakes made in the stock market is recency bias. An investor will naturally overweight the recent results of a business in deriving the correct current valuation for an equity.\nThe current stock price is a prime example for Apple. The tech. giant has a huge history of growing over time, but Apple has also had a couple of periods in the last decade where revenues declined.\nThe recent accelerated growth and shift to recurring services shouldn't alter one's view that Apple is still product-focused and will constantly run into down cycles. Investors must consider these likely outcomes when valuing the stock, but the current valuation is based on a recency bias of elevated growth in the last year.\nData byYCharts\nEven after another sterling quarter, analyst estimates are still forecasting a period of up to 4 years where Apple doesn't generate revenue growth in excess of 6%. TheFQ3'21 resultswere blow away numbers with revenues topping $80 billion and beating estimates by over $8 billion.\nSource: Seeking Alphaearnings estimates\nThe problem is that Apple had a nearly perfect quarter. The company admitted that Services revenue won't repeat the 33% growth in the June quarter and these tough comps are problematic for growth in future periods. Investors should easily understand that any growth after reporting a year with 33% growth is impressive, but some post covid slowdowns shouldn't be surprising.\nRight now though, Apple is still priced for excessive growth. A lot of the stock price gains in the last few years are attributed all to expanding P/E multiples. One only has to go back to 2016 for when Apple only traded at 10x trailing earnings. The stock now trades at nearly 30x trailing earnings, or nearly 3x the multiple from just 5 years ago.\nData byYCharts\nIf Apple only traded at 15x trailing earnings, the stock would trade closer to $75, not $150. For this reason, the stock has struggled to break above $150 for a while now.\nWhile the market forecasts 3% revenue growth for FY22, Citi analyst Wamsi Mohanmade it clearreal risk exists for Apple to actually report revenue and gross profit dollars down YoY in the first 3 quarters of the fiscal year:\n\n Apple could be faced with the dual headwinds of tougher comps and weaker demand in Hardware only modestly offset by any Services re-acceleration. Revenue growth for F4Q was guided lower than the 36% y/y growth in F3Q, but the upcoming Dec, March and now even June quarters could be down y/y in revs and gross profit dollars given several headwinds.\n\niPhone 5G Cycle\nHistory tells us that Apple regularly has these product cycles and covid lockdowns should accelerate the likelihood of a future quarter with trough numbers. In addition, the 5G iPhone cycle should advance these normal cycles with sales pushed from the normal quarter into the December quarter last year. Normal sales for the iPhone 13 in the September quarter will accelerate the tough comps in the December quarter and on into FY22.\nTheCounterpoint chart highlights how the iPhone 12/5G cycle has elevated sales to a level where Apple faces tough comps in FY22. Not only were FQ1'21 sales elevated, but the FQ2'21/FQ3'21 units sold were far in excess of the prior two years.\nNo real explanation exists for higher sales other than covid demand pulled forward and the 5G cycle. Even normal market growth wouldn't lead to unit sales surging somewhere in the 50% range for the March and June quarters from prior-year levels.\nInvestors really have to question whether Apple can sell over 60 million units again in the March quarter and another 50 million units in the June quarter. Even selling iPhones at higher ASPs might not be enough to offset some declines in units sold.\nThe crazy part here is that historical norms support Apple reporting some tough comps in the next year and going on to substantial growth in the next decade. The company has Services revenues up to $17.5 billion in quarterly sales accounting for some 21% of sales for the first 9 months of FY21.\nApple is poised to roll these recurring revenues into more consistent growth, but the growth rates will be as annual revenues top $400 billion. Without the recency bias of the last year, investors would understand this concept and appropriately value the stock at a more normal valuation of ~15x future earnings.\nIf the tech giant earns $5.92 in even FY23, the stock would only trade at $89 using a 15x multiple. Remember, one would normally question whether Apple even deserves a 15x forward multiple when earnings are only forecast to grow at a 5% clip in FY23. A stock usually struggles to trade at forward P/E multiples of 2x the growth rate, not 3x the growth rate.\nTakeaway\nThe key investor takeaway is that investors should clearly understand why Apple is struggling to push beyond $150. The stock is already insanely expensive for the normalized growth rates going forward and the real risk that the tech giant actually reports a few quarters where revenues decline.\nInvestors should be selling Apple at $150, not looking to buy even more shares at a price where the annualized returns should be weak.","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9083831416,"gmtCreate":1650087785589,"gmtModify":1676534645457,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9083831416","repostId":"2227638600","repostType":4,"repost":{"id":"2227638600","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1650064990,"share":"https://www.laohu8.com/m/news/2227638600?lang=&edition=full","pubTime":"2022-04-16 07:23","market":"us","language":"en","title":"Twitter Adopts \"Poison Pill\" to Fight Musk Takeover","url":"https://stock-news.laohu8.com/highlight/detail?id=2227638600","media":"Reuters","summary":"$Twitter$ Inc on Friday adopted a limited-duration shareholder rights plan to protect itself from billionaire entrepreneur Elon Musk's $43 billion cash takeover offer.Musk made the bid on Wednesday in a letter to the board of Twitter- the micro-blogging platform that has become a global means of communication for individuals and world leaders - and it was made public in a regulatory filing on Thursday.After his TED talk on Thursday, Musk hinted at the possibility of a hostile bid in which he wou","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc on Friday adopted a limited-duration shareholder rights plan to protect itself from billionaire entrepreneur Elon Musk&#39;s $43 billion cash takeover offer.</p><p>Musk made the bid on Wednesday in a letter to the board of Twitter- the micro-blogging platform that has become a global means of communication for individuals and world leaders - and it was made public in a regulatory filing on Thursday.</p><p>After his TED talk on Thursday, Musk hinted at the possibility of a hostile bid in which he would bypass Twitter&#39;s board and put the offer directly to its shareholders, tweeting: &#34;It would be utterly indefensible not to put this offer to a shareholder vote.&#34;</p><p>Under the plan, also known as a &#39;poison pill&#39; strategy to resist a bid from a potential acquirer, the rights will become exercisable if anyone acquires ownership of 15% or more of Twitter&#39;s outstanding common stock in a transaction not approved by the Board.</p><p>The rights plan will expire on April 14, 2023, Twitter said.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Twitter Adopts \"Poison Pill\" to Fight Musk Takeover</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTwitter Adopts \"Poison Pill\" to Fight Musk Takeover\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-04-16 07:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc on Friday adopted a limited-duration shareholder rights plan to protect itself from billionaire entrepreneur Elon Musk&#39;s $43 billion cash takeover offer.</p><p>Musk made the bid on Wednesday in a letter to the board of Twitter- the micro-blogging platform that has become a global means of communication for individuals and world leaders - and it was made public in a regulatory filing on Thursday.</p><p>After his TED talk on Thursday, Musk hinted at the possibility of a hostile bid in which he would bypass Twitter&#39;s board and put the offer directly to its shareholders, tweeting: &#34;It would be utterly indefensible not to put this offer to a shareholder vote.&#34;</p><p>Under the plan, also known as a &#39;poison pill&#39; strategy to resist a bid from a potential acquirer, the rights will become exercisable if anyone acquires ownership of 15% or more of Twitter&#39;s outstanding common stock in a transaction not approved by the Board.</p><p>The rights plan will expire on April 14, 2023, Twitter said.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","BK4555":"新能源车","BK4527":"明星科技股","BK4511":"特斯拉概念","BK4099":"汽车制造商","BK4574":"无人驾驶","BK4548":"巴美列捷福持仓","TWTR":"Twitter","BK4551":"寇图资本持仓","TSLA":"特斯拉","BK4534":"瑞士信贷持仓","BK4581":"高盛持仓"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2227638600","content_text":"Twitter Inc on Friday adopted a limited-duration shareholder rights plan to protect itself from billionaire entrepreneur Elon Musk's $43 billion cash takeover offer.Musk made the bid on Wednesday in a letter to the board of Twitter- the micro-blogging platform that has become a global means of communication for individuals and world leaders - and it was made public in a regulatory filing on Thursday.After his TED talk on Thursday, Musk hinted at the possibility of a hostile bid in which he would bypass Twitter's board and put the offer directly to its shareholders, tweeting: \"It would be utterly indefensible not to put this offer to a shareholder vote.\"Under the plan, also known as a 'poison pill' strategy to resist a bid from a potential acquirer, the rights will become exercisable if anyone acquires ownership of 15% or more of Twitter's outstanding common stock in a transaction not approved by the Board.The rights plan will expire on April 14, 2023, Twitter said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9016376568,"gmtCreate":1649136147291,"gmtModify":1676534457865,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>&nbsp;waiting to up","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>&nbsp;waiting to up","text":"$Novavax(NVAX)$ waiting to up","images":[{"img":"https://community-static.tradeup.com/news/974f6808b2f6d5c0e9eac68a81907d52","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9016376568","isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":880071606,"gmtCreate":1631004118305,"gmtModify":1676530439839,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Higher up please.&nbsp;","listText":"Higher up please.&nbsp;","text":"Higher up please.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/880071606","repostId":"1170186591","repostType":4,"repost":{"id":"1170186591","pubTimestamp":1631000826,"share":"https://www.laohu8.com/m/news/1170186591?lang=&edition=full","pubTime":"2021-09-07 15:47","market":"us","language":"en","title":"Japan to purchase 150M doses of Novavax's COVID-19 vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=1170186591","media":"seekingalpha","summary":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 va","content":"<p><i><b>(Update: Sept 7 2021 at 04:31 a.m. ET)</b></i></p>\n<p>The Japanese government has secured 150M doses of COVID-19 vaccine manufactured by <a href=\"https://laohu8.com/S/NVAX\">Novavax</a>,&nbsp;source Reuters.</p>\n<p>The company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.</p>\n<p>The vaccine is expected to be available in Japan in early 2022, pending regulatory approval.</p>\n<p>The terms of the deal with the government are confidential.</p>\n<p>Novavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.</p>\n<p>So far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.</p>\n<p>Takeda is also handling the import and distribution of Moderna's vaccine.</p>\n<p>Three batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.</p>\n<p>Shares&nbsp;of&nbsp;Novavax&nbsp;jumped&nbsp;over&nbsp;2%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d3b7127abe4beb1d4feb41efecdadde8\" tg-width=\"968\" tg-height=\"528\" referrerpolicy=\"no-referrer\"><span>(Update: Sept 7 2021 at 04:31 a.m. ET)</span></p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan to purchase 150M doses of Novavax's COVID-19 vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan to purchase 150M doses of Novavax's COVID-19 vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical...</p>\n\n<a href=\"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"source_url":"https://seekingalpha.com/news/3737388-japan-to-purchase-150m-doses-of-novavaxs-covid-19-vaccine","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170186591","content_text":"(Update: Sept 7 2021 at 04:31 a.m. ET)\nThe Japanese government has secured 150M doses of COVID-19 vaccine manufactured by Novavax, source Reuters.\nThe company's Japanese partner, Takeda Pharmaceutical(NYSE:TAK)will handle local production and supply.\nThe vaccine is expected to be available in Japan in early 2022, pending regulatory approval.\nThe terms of the deal with the government are confidential.\nNovavax is licensing and transferring manufacturing technologies to enable Takeda to manufacture the vaccine, according to the statement.\nSo far, Japan has administered jabs by Pfizer, Moderna and AstraZeneca.\nTakeda is also handling the import and distribution of Moderna's vaccine.\nThree batches of Moderna supplies, or about 1.6M doses, were recalled in Japan afterstainless steel particles were found in some vials.\nShares of Novavax jumped over 2% in premarket trading.\n(Update: Sept 7 2021 at 04:31 a.m. ET)","news_type":1},"isVote":1,"tweetType":1,"viewCount":26,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9061756287,"gmtCreate":1651683107753,"gmtModify":1676534948774,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://community-static.tradeup.com/news/1ada5ec4c0e2d8a04931dc74c6f54775","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061756287","isVote":1,"tweetType":1,"viewCount":55,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://community-static.tradeup.com/news/58fdf90023b13bdabb45b46bb0d645e1","crmLevel":3,"crmLevelSwitch":1},"content":"I know, a long road back. hopefully journey started in ernest.","text":"I know, a long road back. hopefully journey started in ernest.","html":"I know, a long road back. hopefully journey started in ernest."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9038136556,"gmtCreate":1646761667137,"gmtModify":1676534159249,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Gold","listText":"Gold","text":"Gold","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9038136556","repostId":"1104817602","repostType":4,"repost":{"id":"1104817602","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1646751714,"share":"https://www.laohu8.com/m/news/1104817602?lang=&edition=full","pubTime":"2022-03-08 23:01","market":"fut","language":"en","title":"Gold Soared Over 2% to $2049.1 an Ounce; Silver Jumped Over 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1104817602","media":"Tiger Newspress","summary":"Gold soared over 2% to $2049.1 an ounce; silver jumped over 5%.","content":"<html><head></head><body><p>Gold soared over 2% to $2049.1 an ounce; silver jumped over 5%.<img src=\"https://static.tigerbbs.com/b548ca2b39315bf921ef2cca6fb71a41\" tg-width=\"335\" tg-height=\"87\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold Soared Over 2% to $2049.1 an Ounce; Silver Jumped Over 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold Soared Over 2% to $2049.1 an Ounce; Silver Jumped Over 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-08 23:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Gold soared over 2% to $2049.1 an ounce; silver jumped over 5%.<img src=\"https://static.tigerbbs.com/b548ca2b39315bf921ef2cca6fb71a41\" tg-width=\"335\" tg-height=\"87\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1104817602","content_text":"Gold soared over 2% to $2049.1 an ounce; silver jumped over 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3580024367177542","authorId":"3580024367177542","name":"ISSEY1413","avatar":"https://static.tigerbbs.com/3aae359514ad4455bfc28cf62f608a5e","crmLevel":6,"crmLevelSwitch":1},"content":"=whatsapp&skin=1&edition=fundamental&share=whatsapp&invite=93MKO7&lang=en_US&utm_source=invite [Cool] [Cool] [Cool]","text":"=whatsapp&skin=1&edition=fundamental&share=whatsapp&invite=93MKO7&lang=en_US&utm_source=invite [Cool] [Cool] [Cool]","html":"=whatsapp&skin=1&edition=fundamental&share=whatsapp&invite=93MKO7&lang=en_US&utm_source=invite [Cool] [Cool] [Cool]"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860464280,"gmtCreate":1632200052840,"gmtModify":1676530724136,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Wah lao eh&nbsp;","listText":"Wah lao eh&nbsp;","text":"Wah lao eh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860464280","repostId":"2169681424","repostType":4,"repost":{"id":"2169681424","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632178073,"share":"https://www.laohu8.com/m/news/2169681424?lang=&edition=full","pubTime":"2021-09-21 06:47","market":"us","language":"en","title":"Wall Street ends sharply lower in broad sell-off","url":"https://stock-news.laohu8.com/highlight/detail?id=2169681424","media":"Reuters","summary":"* All eyes on Fed's policy meeting later this week\n* Indexes: Dow down 1.8%, S&P 500 down 1.7%, Nasd","content":"<p>* All eyes on Fed's policy meeting later this week</p>\n<p>* Indexes: Dow down 1.8%, S&amp;P 500 down 1.7%, Nasdaq down 2.2%</p>\n<p>NEW YORK, Sept 20 (Reuters) - Wall Street fell in a broad sell-off on Monday, with the S&amp;P 500 and Nasdaq suffering their biggest daily percentage drops since May.</p>\n<p>The Nasdaq also hit its lowest level in about a month, but indexes pared losses just before the close to end well off their lows of the session. The Nasdaq was down more than 3% during the day.</p>\n<p>Microsoft Corp, Alphabet Inc, Amazon.com Inc, Apple Inc, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc and Tesla Inc were among the biggest drags on the Nasdaq and the S&amp;P 500.</p>\n<p>All 11 major S&amp;P 500 sectors were lower, with economically sensitive groups like energy, which fell 3%, down the most. Defensive sectors including utilities were down the least.</p>\n<p>Investors also were nervous ahead of the Federal Reserve's policy meeting this week.</p>\n<p>The banking sub-index dropped 2.9% while U.S. Treasury prices rose.</p>\n<p>Wednesday will bring the results of the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.</p>\n<p>The Dow Jones Industrial Average fell 614.41 points, or 1.78%, to 33,970.47, the S&amp;P 500 lost 75.26 points, or 1.70%, to 4,357.73 and the Nasdaq Composite dropped 330.07 points, or 2.19%, to 14,713.90.</p>\n<p>The Dow registered its biggest daily percentage drop since July, while the CBOE volatility index, known as Wall Street's fear gauge, rose.</p>\n<p>The S&amp;P 500 is now down about 4% from its Sept. 2 record high close.</p>\n<p>Strategists at <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> said they expected a 10% correction in the S&amp;P 500 as the Fed starts to unwind its monetary support, adding that signs of stalling economic growth could deepen it to 20%.</p>\n<p>Most airline carriers ended higher after the United States announced it will relax travel restrictions in November on passengers from China, India, Britain and many other European countries who have received COVID-19 vaccines.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 5.40-to-1 ratio; on Nasdaq, a 4.66-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted no new 52-week highs and three new lows; the Nasdaq Composite recorded 23 new highs and 193 new lows.</p>\n<p>Volume on U.S. exchanges was 12.24 billion shares, compared with the 9.89 billion average for the full session over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street ends sharply lower in broad sell-off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street ends sharply lower in broad sell-off\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-21 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* All eyes on Fed's policy meeting later this week</p>\n<p>* Indexes: Dow down 1.8%, S&amp;P 500 down 1.7%, Nasdaq down 2.2%</p>\n<p>NEW YORK, Sept 20 (Reuters) - Wall Street fell in a broad sell-off on Monday, with the S&amp;P 500 and Nasdaq suffering their biggest daily percentage drops since May.</p>\n<p>The Nasdaq also hit its lowest level in about a month, but indexes pared losses just before the close to end well off their lows of the session. The Nasdaq was down more than 3% during the day.</p>\n<p>Microsoft Corp, Alphabet Inc, Amazon.com Inc, Apple Inc, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc and Tesla Inc were among the biggest drags on the Nasdaq and the S&amp;P 500.</p>\n<p>All 11 major S&amp;P 500 sectors were lower, with economically sensitive groups like energy, which fell 3%, down the most. Defensive sectors including utilities were down the least.</p>\n<p>Investors also were nervous ahead of the Federal Reserve's policy meeting this week.</p>\n<p>The banking sub-index dropped 2.9% while U.S. Treasury prices rose.</p>\n<p>Wednesday will bring the results of the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.</p>\n<p>The Dow Jones Industrial Average fell 614.41 points, or 1.78%, to 33,970.47, the S&amp;P 500 lost 75.26 points, or 1.70%, to 4,357.73 and the Nasdaq Composite dropped 330.07 points, or 2.19%, to 14,713.90.</p>\n<p>The Dow registered its biggest daily percentage drop since July, while the CBOE volatility index, known as Wall Street's fear gauge, rose.</p>\n<p>The S&amp;P 500 is now down about 4% from its Sept. 2 record high close.</p>\n<p>Strategists at <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> said they expected a 10% correction in the S&amp;P 500 as the Fed starts to unwind its monetary support, adding that signs of stalling economic growth could deepen it to 20%.</p>\n<p>Most airline carriers ended higher after the United States announced it will relax travel restrictions in November on passengers from China, India, Britain and many other European countries who have received COVID-19 vaccines.</p>\n<p>Declining issues outnumbered advancing ones on the NYSE by a 5.40-to-1 ratio; on Nasdaq, a 4.66-to-1 ratio favored decliners.</p>\n<p>The S&amp;P 500 posted no new 52-week highs and three new lows; the Nasdaq Composite recorded 23 new highs and 193 new lows.</p>\n<p>Volume on U.S. exchanges was 12.24 billion shares, compared with the 9.89 billion average for the full session over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","IVV":"标普500指数ETF","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","QLD":"纳指两倍做多ETF","QQQ":"纳指100ETF","SSO":"两倍做多标普500ETF","SDOW":"道指三倍做空ETF-ProShares",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","SQQQ":"纳指三倍做空ETF","SDS":"两倍做空标普500ETF","OEX":"标普100","SH":"标普500反向ETF",".SPX":"S&P 500 Index","SPXU":"三倍做空标普500ETF","DDM":"道指两倍做多ETF","QID":"纳指两倍做空ETF","UPRO":"三倍做多标普500ETF","DOG":"道指反向ETF","UDOW":"道指三倍做多ETF-ProShares","DJX":"1/100道琼斯","SPY":"标普500ETF","OEF":"标普100指数ETF-iShares","DXD":"道指两倍做空ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169681424","content_text":"* All eyes on Fed's policy meeting later this week\n* Indexes: Dow down 1.8%, S&P 500 down 1.7%, Nasdaq down 2.2%\nNEW YORK, Sept 20 (Reuters) - Wall Street fell in a broad sell-off on Monday, with the S&P 500 and Nasdaq suffering their biggest daily percentage drops since May.\nThe Nasdaq also hit its lowest level in about a month, but indexes pared losses just before the close to end well off their lows of the session. The Nasdaq was down more than 3% during the day.\nMicrosoft Corp, Alphabet Inc, Amazon.com Inc, Apple Inc, Facebook Inc and Tesla Inc were among the biggest drags on the Nasdaq and the S&P 500.\nAll 11 major S&P 500 sectors were lower, with economically sensitive groups like energy, which fell 3%, down the most. Defensive sectors including utilities were down the least.\nInvestors also were nervous ahead of the Federal Reserve's policy meeting this week.\nThe banking sub-index dropped 2.9% while U.S. Treasury prices rose.\nWednesday will bring the results of the Fed's policy meeting, where the central bank is expected to lay the groundwork for a tapering, although the consensus is for an actual announcement to be delayed until the November or December meetings.\nThe Dow Jones Industrial Average fell 614.41 points, or 1.78%, to 33,970.47, the S&P 500 lost 75.26 points, or 1.70%, to 4,357.73 and the Nasdaq Composite dropped 330.07 points, or 2.19%, to 14,713.90.\nThe Dow registered its biggest daily percentage drop since July, while the CBOE volatility index, known as Wall Street's fear gauge, rose.\nThe S&P 500 is now down about 4% from its Sept. 2 record high close.\nStrategists at Morgan Stanley said they expected a 10% correction in the S&P 500 as the Fed starts to unwind its monetary support, adding that signs of stalling economic growth could deepen it to 20%.\nMost airline carriers ended higher after the United States announced it will relax travel restrictions in November on passengers from China, India, Britain and many other European countries who have received COVID-19 vaccines.\nDeclining issues outnumbered advancing ones on the NYSE by a 5.40-to-1 ratio; on Nasdaq, a 4.66-to-1 ratio favored decliners.\nThe S&P 500 posted no new 52-week highs and three new lows; the Nasdaq Composite recorded 23 new highs and 193 new lows.\nVolume on U.S. exchanges was 12.24 billion shares, compared with the 9.89 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812357272,"gmtCreate":1630556235296,"gmtModify":1676530339635,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Higher higher","listText":"Higher higher","text":"Higher higher","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/812357272","repostId":"2164481914","repostType":4,"repost":{"id":"2164481914","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1630529217,"share":"https://www.laohu8.com/m/news/2164481914?lang=&edition=full","pubTime":"2021-09-02 04:46","market":"us","language":"en","title":"Tech stocks send Nasdaq to fresh record close, boost S&P","url":"https://stock-news.laohu8.com/highlight/detail?id=2164481914","media":"Reuters","summary":"Gains for tech stocks, utilities and real estate.\nAugust private jobs growth misses expectations.\nIn","content":"<ul>\n <li>Gains for tech stocks, utilities and real estate.</li>\n <li>August private jobs growth misses expectations.</li>\n <li>Indexes: Dow falls 0.14%, S&amp;P up 0.03%, Nasdaq rises 0.33%.</li>\n</ul>\n<p>Sept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&amp;P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.</p>\n<p>Technology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.</p>\n<p>Utilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.</p>\n<p>\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.</p>\n<p>Wall Street's main indexes have hit record highs recently, with the benchmark S&amp;P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.</p>\n<p>Each new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.</p>\n<p>A report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.</p>\n<p>Another set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.</p>\n<p>\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.</p>\n<p>The Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&amp;P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.</p>\n<p>Falling 1.5% on the day, and down for the third straight session, was the energy index.</p>\n<p>Crude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established&nbsp;More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.</p>\n<p><a href=\"https://laohu8.com/S/PBF\">PBF Energy</a> Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.</p>\n<p>Volume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.</p>\n<p>The S&amp;P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech stocks send Nasdaq to fresh record close, boost S&P</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech stocks send Nasdaq to fresh record close, boost S&P\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-02 04:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Gains for tech stocks, utilities and real estate.</li>\n <li>August private jobs growth misses expectations.</li>\n <li>Indexes: Dow falls 0.14%, S&amp;P up 0.03%, Nasdaq rises 0.33%.</li>\n</ul>\n<p>Sept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&amp;P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.</p>\n<p>Technology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.</p>\n<p>Utilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.</p>\n<p>\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.</p>\n<p>Wall Street's main indexes have hit record highs recently, with the benchmark S&amp;P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.</p>\n<p>Each new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.</p>\n<p>A report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.</p>\n<p>Another set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.</p>\n<p>\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.</p>\n<p>The Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&amp;P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.</p>\n<p>Falling 1.5% on the day, and down for the third straight session, was the energy index.</p>\n<p>Crude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established&nbsp;More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.</p>\n<p><a href=\"https://laohu8.com/S/PBF\">PBF Energy</a> Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.</p>\n<p>Volume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.</p>\n<p>The S&amp;P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.</p>\n<p>(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2164481914","content_text":"Gains for tech stocks, utilities and real estate.\nAugust private jobs growth misses expectations.\nIndexes: Dow falls 0.14%, S&P up 0.03%, Nasdaq rises 0.33%.\n\nSept 1 (Reuters) - The Nasdaq closed Wednesday at a record high, and the S&P 500 rose but just missed a fresh peak, as September kicked off with renewed buying of technology stocks and private payrolls data, which supported the case for dovish monetary policy.\nTechnology stocks , which tend to benefit from a low-rate environment, finished higher. Apple Inc rose 0.4% to its second-highest close, and Facebook Inc , Amazon.com Inc and Google-owner Alphabet Inc all advanced between 0.2% and 0.7%.\nUtilities and real estate - sectors considered as bond-proxies or defensive - were the top performers.\n\"Given there's going to be some choppiness in the economic recovery because of COVID, people will look for where they can find the best future growth potential,\" said Chris Graff, co-chief investment officer at RMB Capital.\nWall Street's main indexes have hit record highs recently, with the benchmark S&P 500 notching seven straight monthly gains as investors shrugged off risks around a rise in new coronavirus infections and hoped for the Fed to remain dovish in its policy stance.\nEach new data release though is viewed by investors through the prism of whether it could push the Fed to taper sooner rather than later.\nA report by ADP, published ahead of the U.S. government's more comprehensive employment report on Friday, showed private employers hired far fewer workers than expected in August.\nAnother set of data on Wednesday showed U.S. manufacturing activity unexpectedly picked up in August amid strong order growth, but a measure of factory employment dropped to a nine-month low, likely as workers remained scarce.\n\"We've got the jobs report on Friday, but what's become more important is the job openings report next week and the CPI release after that, so a lot about employment and inflation in the next couple of weeks which will reset people's expectations for tapering and interest rates,\" Graff added.\nThe Dow Jones Industrial Average fell 48.2 points, or 0.14%, to 35,312.53, the S&P 500 gained 1.41 points, or 0.03%, to 4,524.09 and the Nasdaq Composite added 50.15 points, or 0.33%, to 15,309.38.\nFalling 1.5% on the day, and down for the third straight session, was the energy index.\nCrude prices were flat after OPEC and its allies agreed to stick to their existing policy of gradual output increases. However, the full extent of damage to U.S. energy infrastructure from Hurricane Ida is still being established More than 80% of oil and gas production in the Gulf of Mexico remains offline, while analysts have warned that restarting Louisiana refineries shut by the storm could take weeks and cost operators tens of millions of dollars in lost revenue.\nPBF Energy Inc , whose 190,000 barrel-per-day Chalmette, Louisiana, refinery lost power following the storm, slumped 6.8% on Wednesday, taking its losses this week to 11.2%.\nVolume on U.S. exchanges was 9.81 billion shares, compared with the 8.99 billion average for the full session over the last 20 trading days.\nThe S&P 500 posted 55 new 52-week highs and no new lows; the Nasdaq Composite recorded 131 new highs and 17 new lows.\n(Reporting by Shashank Nayar in Bengaluru and David French in New York; Editing by Aditya Soni and Lisa Shumaker)","news_type":1},"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175128991,"gmtCreate":1627015343713,"gmtModify":1703482491195,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"Drink coca cola and be rich. Lol","listText":"Drink coca cola and be rich. Lol","text":"Drink coca cola and be rich. Lol","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/175128991","repostId":"2153787206","repostType":4,"repost":{"id":"2153787206","pubTimestamp":1627011840,"share":"https://www.laohu8.com/m/news/2153787206?lang=&edition=full","pubTime":"2021-07-23 11:44","market":"us","language":"en","title":"Warren Buffett Has Gained Over $181 Billion on These 5 Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2153787206","media":"Motley Fool","summary":"These five holdings account for 88% of Berkshire Hathaway's unrealized gains.","content":"<p><b>Berkshire Hathaway</b> (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of Omaha has led his stock to an average annual return of 20%. Taking into account the 20% year-to-date gain for Berkshire's Class A shares (BRK.A), shareholders have seen Buffett generate aggregate returns of almost 3,400,000% in 56 years.</p>\n<p>Although Berkshire Hathaway has a relatively large portfolio filled with four dozen different securities, Buffett has never been a big fan of diversification. As a result, only a small number of holdings comprise the bulk of Berkshire Hathaway's $206.4 billion in unrealized gains, as of this past weekend.</p>\n<p>Based on the cost basis of Berkshire's major holdings (outlined in the company's 2020 annual shareholder letter), the following five stocks have netted Buffett $181.1 billion in combined unrealized gains (about 88% of all current unrealized profit), not including dividends paid.</p>\n<p><img src=\"https://static.tigerbbs.com/d28b3a8823057ce2bc2495cefe7ee3ff\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Berkshire Hathaway CEO Warren Buffett is all smiles with his company sitting on over $206 billion in unrealized gains. Image source: The Motley Fool.</p>\n<h3>Apple: $101,764,676,001 in unrealized gains</h3>\n<p>Easily the best investment of Buffett's tenured career is <b>Apple</b> (NASDAQ:AAPL). Even after modestly paring down his company's stake in the tech kingpin, Berkshire Hathaway still owns 907,559,761 shares at a cost basis of $34.26 a share. With Apple closing last week at $146.39 a share, the Oracle of Omaha and his team are sitting on close to a $102 billion unrealized gain.</p>\n<p>Investors certainly shouldn't look for this stake to be reduced any further anytime soon. That's because Buffett views Apple as Berkshire Hathaway's \"third business.\" It's a globally recognized brand with an exceptionally loyal following, as evidenced by the mammoth lines outside of its stores anytime a new product hits the shelves. And, as you're probably aware, the iPhone is the dominant smartphone by market share in the U.S.</p>\n<p>In addition to Apple being a product innovation juggernaut, CEO Tim Cook is overseeing a steady transition toward services. By emphasizing various subscription-based platforms, Apple can reduce some of the revenue lumpiness associated with tech replacement cycles and likely boost its operating margins.</p>\n<p>A final reason Buffett isn't bailing on Apple is the company's generous shareholder return program. Though some of you might be scratching your head given that Apple's dividend yield is \"only\" 0.6%, the $0.88 base annual payout is closer to 2.6% of Berkshire Hathaway's cost basis. Tack on Apple's aggressive share repurchase program and you have a very shareholder-friendly company.</p>\n<p><img src=\"https://static.tigerbbs.com/44a30c4dfd6886a29e22d3c6558c3e56\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Bank of America: $24,530,235,143 in unrealized gains</h3>\n<p>There's no industry on the planet Buffett loves more than bank stocks -- and there's no bank stock Buffett favors more than <b>Bank of America</b> (NYSE:BAC). Berkshire Hathaway owns over 1.03 billion shares of BofA with a cost basis of $14.17 a share. This works out to an unrealized gain of just over $24.5 billion, based on where BofA shares closed this past Friday, July 16.</p>\n<p>Buffett has always been a big fan of playing the economic numbers game, which is exactly what he's doing with Bank of America. Since the U.S. economy spends a disproportionate amount of time expanding, relative to contracting, bank stocks like BofA should benefit from stronger loan origination and higher net interest income. The Oracle of Omaha is fully aware that recessions are a natural part of the economic cycle, but he fully understands that the long term strongly favors optimists.</p>\n<p>More specific to the business, BofA stands to benefit from eventual interest rate hikes by the Federal Reserve. Bank of America is the most interest-sensitive of all the big banks, with the company noting in the June-ended quarter that a 100 basis point parallel shift in the interest rate yield curve would net it an extra $8 billion in net interest income over the next 12 months.</p>\n<p>With BofA pushing digitization initiatives and bolstering its dividend program, it's far likelier that Buffett ups his stake in the company than sells a single share.</p>\n<p><img src=\"https://static.tigerbbs.com/ed3e6a16841306014bf0cfc3b1697b23\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: American <a href=\"https://laohu8.com/S/EXPR\">Express</a>.</p>\n<h2>American Express: $24,488,160,264 in unrealized gains</h2>\n<p>Whereas the gains racked up in Apple and BofA have come within the past couple of years, the nearly $24.5 billion in unrealized gains in credit services behemoth <b>American Express</b> (NYSE:AXP) have been built up over the past 28 years. With a cost basis of right around $8.49 a share, Buffett's patience has paid off in a big way with AmEx.</p>\n<p>Similar to Bank of America, American Express is a cyclical company that benefits from the aforementioned numbers game. If the U.S. and global economy are expanding, consumers and businesses are more likely to spend more, thereby helping boost payment processing revenue and profits. Keep in mind, though, AmEx is a double dipper. In addition to processing payments, it's also a credit services provider. This means it can generate growing amounts of fee revenue and interest income during long-winded periods of expansion.</p>\n<p>Another facet to AmEx's success is the company's ability to bring in affluent clientele. The well-to-do are far less inclined to alter their spending habits when minor economic disruptions rear their heads. As a result, AmEx isn't as likely to be hurt by credit delinquencies as some of its lending peers.</p>\n<p>With Berkshire Hathaway an American Express shareholder since 1993, I don't foresee Buffett or his team selling shares anytime soon.</p>\n<p><img src=\"https://static.tigerbbs.com/299023e9f7694c143fc3162fbb154afa\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Coca-Cola.</p>\n<h3>Coca-Cola: $21,262,000,000 in unrealized gains</h3>\n<p>Speaking of tenured holdings, no stock has been a fixture in Buffett's portfolio for longer than beverage giant <b>Coca-Cola</b> (NYSE:KO). With a cost basis of a fraction under $3.25 a share, Buffett and his team have piled up almost $21.3 billion in unrealized gains by owning Coca-Cola since 1988.</p>\n<p>Like Apple, we're talking about a company with insanely strong branding and brand recognition. Coke products are sold in all but two countries worldwide (Cuba and North Korea), and it has more than 20 brands in its product portfolio generating at least $1 billion in annual sales. Coca-Cola enjoys the best of both worlds, with 20% of the developed market cold beverage share (i.e., highly predictable cash flow) and 10% of emerging market cold beverage share, which represents a higher-growth opportunity over the long run.</p>\n<p>Beyond geographic diversity, marketing is a big reason for Coca-Cola's success. The company has not been shy about turning to social media and well-known ambassadors to represent its brand, and it has clear holiday tie-ins that go back decades.</p>\n<p>Considering that Berkshire Hathaway is netting almost a 52% annual dividend yield based on its original cost basis for Coca-Cola, there's absolutely no incentive to sell this position.</p>\n<p><img src=\"https://static.tigerbbs.com/0405d7e87cf0321a7d9113d036c164a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Moody's: $9,076,258,024 in unrealized gains</h3>\n<p>While Apple singlehandedly takes the crown for generating the highest unrealized return in nominal dollars for the Oracle of Omaha, credit ratings agency <b>Moody's</b> (NYSE:MCO) might well be Warren Buffett's greatest investment on a percentage basis of all time. Berkshire's cost basis is $10.05 a share following Moody's spinoff from Dun &amp; Bradstreet in 2000. Moody's closed this past week at almost $378 a share -- good enough for a 3,661% return and nearly $9.1 billion unrealized gain.</p>\n<p>One thing keeping Moody's busy is historically low lending rates. With the Federal Reserve standing pat for as long as possible on interest rates, businesses haven't been shy about issuing debt to hire, acquire, innovate, or even buy back stock, as in Apple's case. With so much corporate debt issued, Moody's has been active evaluating the debt landscape.</p>\n<p>Equally exciting has been the generally heightened levels of market volatility and economic uncertainty since the beginning of 2020. Though Moody's is best known for its credit ratings operations, its fastest-growing segment tends to be analytics. As long as deep levels of uncertainty exist, Moody's Analytics has double-digit annual growth potential.</p>\n<p>As with Coke, Buffett's patience has resulted in an insanely high yield on cost with Moody's. Despite a 0.7% nominal yield, Berkshire Hathaway is netting an almost 25% yield annually, based on its initial cost basis.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Warren Buffett Has Gained Over $181 Billion on These 5 Stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWarren Buffett Has Gained Over $181 Billion on These 5 Stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 11:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.A":"伯克希尔","AXP":"美国运通","AAPL":"苹果","KO":"可口可乐","MCO":"穆迪","BAC":"美国银行","BRK.B":"伯克希尔B"},"source_url":"https://www.fool.com/investing/2021/07/22/warren-buffett-gained-181-billion-these-5-stocks/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153787206","content_text":"Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) CEO Warren Buffett is arguably in a class of his own when it comes to investing legends. Since taking the helm of Berkshire Hathaway in 1965, the Oracle of Omaha has led his stock to an average annual return of 20%. Taking into account the 20% year-to-date gain for Berkshire's Class A shares (BRK.A), shareholders have seen Buffett generate aggregate returns of almost 3,400,000% in 56 years.\nAlthough Berkshire Hathaway has a relatively large portfolio filled with four dozen different securities, Buffett has never been a big fan of diversification. As a result, only a small number of holdings comprise the bulk of Berkshire Hathaway's $206.4 billion in unrealized gains, as of this past weekend.\nBased on the cost basis of Berkshire's major holdings (outlined in the company's 2020 annual shareholder letter), the following five stocks have netted Buffett $181.1 billion in combined unrealized gains (about 88% of all current unrealized profit), not including dividends paid.\n\nBerkshire Hathaway CEO Warren Buffett is all smiles with his company sitting on over $206 billion in unrealized gains. Image source: The Motley Fool.\nApple: $101,764,676,001 in unrealized gains\nEasily the best investment of Buffett's tenured career is Apple (NASDAQ:AAPL). Even after modestly paring down his company's stake in the tech kingpin, Berkshire Hathaway still owns 907,559,761 shares at a cost basis of $34.26 a share. With Apple closing last week at $146.39 a share, the Oracle of Omaha and his team are sitting on close to a $102 billion unrealized gain.\nInvestors certainly shouldn't look for this stake to be reduced any further anytime soon. That's because Buffett views Apple as Berkshire Hathaway's \"third business.\" It's a globally recognized brand with an exceptionally loyal following, as evidenced by the mammoth lines outside of its stores anytime a new product hits the shelves. And, as you're probably aware, the iPhone is the dominant smartphone by market share in the U.S.\nIn addition to Apple being a product innovation juggernaut, CEO Tim Cook is overseeing a steady transition toward services. By emphasizing various subscription-based platforms, Apple can reduce some of the revenue lumpiness associated with tech replacement cycles and likely boost its operating margins.\nA final reason Buffett isn't bailing on Apple is the company's generous shareholder return program. Though some of you might be scratching your head given that Apple's dividend yield is \"only\" 0.6%, the $0.88 base annual payout is closer to 2.6% of Berkshire Hathaway's cost basis. Tack on Apple's aggressive share repurchase program and you have a very shareholder-friendly company.\n\nImage source: Getty Images.\nBank of America: $24,530,235,143 in unrealized gains\nThere's no industry on the planet Buffett loves more than bank stocks -- and there's no bank stock Buffett favors more than Bank of America (NYSE:BAC). Berkshire Hathaway owns over 1.03 billion shares of BofA with a cost basis of $14.17 a share. This works out to an unrealized gain of just over $24.5 billion, based on where BofA shares closed this past Friday, July 16.\nBuffett has always been a big fan of playing the economic numbers game, which is exactly what he's doing with Bank of America. Since the U.S. economy spends a disproportionate amount of time expanding, relative to contracting, bank stocks like BofA should benefit from stronger loan origination and higher net interest income. The Oracle of Omaha is fully aware that recessions are a natural part of the economic cycle, but he fully understands that the long term strongly favors optimists.\nMore specific to the business, BofA stands to benefit from eventual interest rate hikes by the Federal Reserve. Bank of America is the most interest-sensitive of all the big banks, with the company noting in the June-ended quarter that a 100 basis point parallel shift in the interest rate yield curve would net it an extra $8 billion in net interest income over the next 12 months.\nWith BofA pushing digitization initiatives and bolstering its dividend program, it's far likelier that Buffett ups his stake in the company than sells a single share.\n\nImage source: American Express.\nAmerican Express: $24,488,160,264 in unrealized gains\nWhereas the gains racked up in Apple and BofA have come within the past couple of years, the nearly $24.5 billion in unrealized gains in credit services behemoth American Express (NYSE:AXP) have been built up over the past 28 years. With a cost basis of right around $8.49 a share, Buffett's patience has paid off in a big way with AmEx.\nSimilar to Bank of America, American Express is a cyclical company that benefits from the aforementioned numbers game. If the U.S. and global economy are expanding, consumers and businesses are more likely to spend more, thereby helping boost payment processing revenue and profits. Keep in mind, though, AmEx is a double dipper. In addition to processing payments, it's also a credit services provider. This means it can generate growing amounts of fee revenue and interest income during long-winded periods of expansion.\nAnother facet to AmEx's success is the company's ability to bring in affluent clientele. The well-to-do are far less inclined to alter their spending habits when minor economic disruptions rear their heads. As a result, AmEx isn't as likely to be hurt by credit delinquencies as some of its lending peers.\nWith Berkshire Hathaway an American Express shareholder since 1993, I don't foresee Buffett or his team selling shares anytime soon.\n\nImage source: Coca-Cola.\nCoca-Cola: $21,262,000,000 in unrealized gains\nSpeaking of tenured holdings, no stock has been a fixture in Buffett's portfolio for longer than beverage giant Coca-Cola (NYSE:KO). With a cost basis of a fraction under $3.25 a share, Buffett and his team have piled up almost $21.3 billion in unrealized gains by owning Coca-Cola since 1988.\nLike Apple, we're talking about a company with insanely strong branding and brand recognition. Coke products are sold in all but two countries worldwide (Cuba and North Korea), and it has more than 20 brands in its product portfolio generating at least $1 billion in annual sales. Coca-Cola enjoys the best of both worlds, with 20% of the developed market cold beverage share (i.e., highly predictable cash flow) and 10% of emerging market cold beverage share, which represents a higher-growth opportunity over the long run.\nBeyond geographic diversity, marketing is a big reason for Coca-Cola's success. The company has not been shy about turning to social media and well-known ambassadors to represent its brand, and it has clear holiday tie-ins that go back decades.\nConsidering that Berkshire Hathaway is netting almost a 52% annual dividend yield based on its original cost basis for Coca-Cola, there's absolutely no incentive to sell this position.\n\nImage source: Getty Images.\nMoody's: $9,076,258,024 in unrealized gains\nWhile Apple singlehandedly takes the crown for generating the highest unrealized return in nominal dollars for the Oracle of Omaha, credit ratings agency Moody's (NYSE:MCO) might well be Warren Buffett's greatest investment on a percentage basis of all time. Berkshire's cost basis is $10.05 a share following Moody's spinoff from Dun & Bradstreet in 2000. Moody's closed this past week at almost $378 a share -- good enough for a 3,661% return and nearly $9.1 billion unrealized gain.\nOne thing keeping Moody's busy is historically low lending rates. With the Federal Reserve standing pat for as long as possible on interest rates, businesses haven't been shy about issuing debt to hire, acquire, innovate, or even buy back stock, as in Apple's case. With so much corporate debt issued, Moody's has been active evaluating the debt landscape.\nEqually exciting has been the generally heightened levels of market volatility and economic uncertainty since the beginning of 2020. Though Moody's is best known for its credit ratings operations, its fastest-growing segment tends to be analytics. As long as deep levels of uncertainty exist, Moody's Analytics has double-digit annual growth potential.\nAs with Coke, Buffett's patience has resulted in an insanely high yield on cost with Moody's. Despite a 0.7% nominal yield, Berkshire Hathaway is netting an almost 25% yield annually, based on its initial cost basis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3552850525395609","authorId":"3552850525395609","name":"moliya","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":2,"crmLevelSwitch":1},"content":"no way drink coca-cola. buy coca-cola stock before you drink cola and hold it for long to become roch","text":"no way drink coca-cola. buy coca-cola stock before you drink cola and hold it for long to become roch","html":"no way drink coca-cola. buy coca-cola stock before you drink cola and hold it for long to become roch"}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9018358578,"gmtCreate":1648982221058,"gmtModify":1676534431587,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://community-static.tradeup.com/news/05f11944800814951ca1b7b676901c18","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9018358578","isVote":1,"tweetType":1,"viewCount":64,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3583106134648492","authorId":"3583106134648492","name":"Frosty4ever","avatar":"https://community-static.tradeup.com/news/58fdf90023b13bdabb45b46bb0d645e1","crmLevel":3,"crmLevelSwitch":1},"content":"sadly still no FDA approval. when the world is still suffering from Covid.","text":"sadly still no FDA approval. when the world is still suffering from Covid.","html":"sadly still no FDA approval. when the world is still suffering from Covid."}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":9031768972,"gmtCreate":1646670343820,"gmtModify":1676534149012,"author":{"id":"3585981947031986","authorId":"3585981947031986","name":"RO8","avatar":"https://static.tigerbbs.com/1f744cb66900b3865c3ed1da7364ddce","crmLevel":2,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","listText":"<a href=\"https://ttm.financial/S/NVAX\">$Novavax(NVAX)$</a>[Cry]&nbsp;","text":"$Novavax(NVAX)$[Cry]","images":[{"img":"https://static.itradeup.com/news/199fd4101d53132ebdde049cb1012962","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9031768972","isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"lives":[]}